<SEC-DOCUMENT>0000950142-25-002929.txt : 20251110
<SEC-HEADER>0000950142-25-002929.hdr.sgml : 20251110
<ACCEPTANCE-DATETIME>20251110162140
ACCESSION NUMBER:		0000950142-25-002929
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251110
DATE AS OF CHANGE:		20251110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RED ROBIN GOURMET BURGERS INC
		CENTRAL INDEX KEY:			0001171759
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-EATING PLACES [5812]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				841573084
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280228
		FILM NUMBER:		251466538

	BUSINESS ADDRESS:	
		STREET 1:		10000 EAST GEDDES AVENUE
		STREET 2:		SUITE 500
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		3038466000

	MAIL ADDRESS:	
		STREET 1:		10000 EAST GEDDES AVENUE
		STREET 2:		SUITE 500
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>eh250702613_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&hairsp;&hairsp;Filed Pursuant to Rule 424(b)(5)&NegativeThickSpace; </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><B>Registration No. 333-280228</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>(To Prospectus dated July 5, 2024)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 94px; width: 204px"></FONT></P>



<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Red Robin Gourmet Burgers,&nbsp;Inc.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Up to $40,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We have entered into a distribution agreement
(the &ldquo;distribution agreement&rdquo;) with Evercore Group L.L.C. (&ldquo;Evercore&rdquo;) relating to shares of our common stock,
$0.001 par value per share (the &ldquo;Common Stock&rdquo;), offered by this prospectus supplement and the accompanying prospectus. In
accordance with the terms of the distribution agreement, from time to time we may offer and sell shares of our Common Stock having an
aggregate gross sales price of up to $40,000,000 through or to Evercore, acting as sales agent, pursuant to this prospectus supplement
and the accompanying prospectus. Sales of Common Stock, if any, may be made on the Nasdaq Global Select Market at market prices or on
mutually agreed terms between Evercore and us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Our Common Stock is traded on the Nasdaq Global
Select Market under the symbol &ldquo;RRGB.&rdquo; The last reported sale price of our Common Stock as reported on the Nasdaq Global Select
Market on November 7, 2025 was $4.69 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Sales of our Common Stock, if any, under this
prospectus supplement may be made in sales deemed to be an &ldquo;at the market offering&rdquo; as defined in Rule&nbsp;415(a)(4) promulgated
under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). Subject to terms of the distribution agreement, Evercore
is not required to sell any specific number or dollar amounts of securities but will use commercially reasonable efforts consistent with
its normal trading and sales practices, on mutually agreed terms between Evercore and us. There is no arrangement for funds to be received
in any escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Evercore will be entitled to compensation under
the terms of the distribution agreement at a fixed commission rate of up to 3% of the gross sales price per share sold. In connection
with the sale of our Common Stock on our behalf, Evercore will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the
Securities Act and the compensation of Evercore will be deemed to be underwriting commissions or discounts. We have also agreed to provide
indemnification and contributions to Evercore against certain liabilities, including liabilities under the Securities Act and the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><B>Investing in our securities involves significant
risks. We strongly recommend that you read carefully the risks we describe in this prospectus supplement and the risk factors that are
incorporated by reference into this prospectus supplement and the accompanying base prospectus from our filings made with the Securities
and Exchange Commission. See &ldquo;<I>Risk Factors</I>&rdquo; beginning on page&nbsp;<A HREF="#ps_006">S-4</A> of this prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the
accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Evercore ISI </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">The date of this prospectus supplement is November
10, 2025.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="toc"></A><U>TABLE OF CONTENTS</U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 94%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Prospectus Supplement</U></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_001">ABOUT THIS PROSPECTUS SUPPLEMENT</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;ii</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_002">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;ii</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_003">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;iii</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_004">FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;iv</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_005">PROSPECTUS SUPPLEMENT SUMMARY</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;1</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_006">RISK FACTORS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;4</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_007">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;6</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_008">DILUTION</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;7</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_009">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;8</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_010">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;9</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ps_011">EXPERTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S&#45;9</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 94%; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Prospectus</U></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 6%; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_002">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_003">INCORPORATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_004">FORWARD&#45;LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_005">THE COMPANY</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_006">RISK FACTORS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_007">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_008">DESCRIPTION OF CAPITAL STOCK</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_009">DESCRIPTION OF THE DEBT SECURITIES</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_010">DESCRIPTION OF THE DEPOSITARY SHARES</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_011">DESCRIPTION OF THE WARRANTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_012">DESCRIPTION OF THE RIGHTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_013">DESCRIPTION OF THE PURCHASE CONTRACTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_014">DESCRIPTION OF THE UNITS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_015">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_016">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="background-color: rgb(198,244,249)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_017">EXPERTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="ps_001"></A><B>ABOUT THIS PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This prospectus supplement and the accompanying
prospectus relate to an offering of our Common Stock. Before buying any of the securities that we are offering, we urge you to carefully
read this prospectus supplement and the accompanying prospectus, together with the information incorporated by reference as described
under &#8220;<I>Where You Can Find More Information</I>&#8221; and &#8220;<I>Incorporation of Certain Information by Reference</I>&#8221;
in this prospectus supplement. These documents contain important information that you should consider when making your investment decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This document is in two parts. The first part
is this prospectus supplement, which describes the terms of this offering and also adds to, updates and changes information contained
in the accompanying prospectus and the documents incorporated by reference. The second part is the accompanying prospectus, which gives
more general information. To the extent the information contained in this prospectus supplement differs from or conflicts with the information
contained in the accompanying prospectus or any document incorporated by reference, the information in this prospectus supplement will
control. If any statement in one of these documents is inconsistent with a statement in another document having a later date&#8212;for
example, a document incorporated by reference into this prospectus supplement or the accompanying prospectus&#8212;the statement in the
document having the later date modifies or supersedes the earlier statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Neither we nor Evercore have authorized anyone
to provide you with information different from that which is contained in or incorporated by reference in this prospectus supplement,
the accompanying prospectus and in any free writing prospectus that we have authorized for use in connection with this offering. No one
is making offers to sell or seeking offers to buy these securities in any jurisdiction where the offer or sale is not permitted. You should
assume that the information contained in this prospectus supplement is accurate as of the date on the front cover of this prospectus supplement
only and that any information we have incorporated by reference or included in the accompanying prospectus is accurate only as of the
date given in the document incorporated by reference or as of the date of the prospectus, as applicable, regardless of the time of delivery
of this prospectus supplement, the accompanying prospectus, any related free writing prospectus, or any sale of our securities. Our business,
financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference into this prospectus
supplement or the accompanying prospectus were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such
representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Unless the context requires otherwise, references
in this prospectus supplement and the accompanying prospectus to &#8220;Red Robin,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221;
&#8220;us&#8221; and &#8220;our&#8221; refer to Red Robin Gourmet Burgers,&nbsp;Inc. and its consolidated subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="ps_002"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As required by the Securities Act, we filed
a registration statement relating to the securities offered by this prospectus supplement with the Securities and Exchange Commission
(the &#8220;SEC&#8221;). This prospectus supplement is a part of that registration statement, which includes additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We are subject to the reporting requirements
of the Exchange Act, and are required to file with the SEC annual, quarterly and current reports, proxy statements and other information.
Such reports include our audited financial statements. Our publicly available filings can be found on the SEC&#8217;s website at <I>www.sec.gov</I>.
Our filings, including the audited financial and additional information that we have made public to investors, may also be found on our
website at <I>www.redrobin.com</I>. Information on or accessible through our website does not constitute part of this prospectus supplement
or the accompanying prospectus (except for SEC reports expressly incorporated by reference herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As permitted by SEC rules, this prospectus does
not contain all of the information we have included in the registration statement and the accompanying exhibits and schedules we file
with the SEC. You may refer to the registration statement, exhibits and schedules for more information about us and the securities. The
registration statement, exhibits and schedules are available through the SEC&#8217;s website.</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="ps_003"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The SEC allows us to &#8220;incorporate by reference&#8221;
the information we file with the SEC, which means that we can disclose important information to you by referring you to those documents.
The information incorporated by reference is considered to be part of this prospectus supplement. Information that we file later with
the SEC will automatically update and supersede information in this prospectus supplement. In all cases, you should rely on the later
information over different information included in this prospectus supplement. The following documents have been filed by us with the
SEC and are incorporated by reference into this prospectus supplement:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>our Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175925000012/rrgb-20241229.htm">Form 10-K</A> for the fiscal year ended December 29, 2024, filed with the SEC on February 26, 2025, including portions
of our <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000110465925038610/tm252334-4_def14a.htm">Proxy Statement</A> for the 2025 annual meeting of stockholders (filed on April 24, 2025) to the extent specifically incorporated by
reference therein;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>our Quarterly Reports on Form 10-Q for the quarters ended April
                                            20, 2025, July 13, 2025 and October 5, 2025, filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175924000020/rrgb-20240421.htm">May
                                            29, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175925000028/rrgb-20250713.htm">August
                                            14, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000162828025051046/rrgb-20251005.htm">November 10, 2025</A>, respectively;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>our Current Reports on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000095014225000317/eh250589715_8k.htm">February
                                                                    11, 2025</A> (as amended on <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000095014225000644/eh250599621_8ka1.htm">March
                                                                    6, 2025</A>), <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000095014225001161/eh250618999_8k.htm">April 24, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000110465925052507/tm2516105d1_8k.htm">May
                                                                    23, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175925000032/rrgb-20250816.htm">August 20, 2025</A> (as
                                                                    amended on <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000095014225002328/eh250672714_8ka1.htm">August 29, 2025</A>), <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000095014225002682/eh250686446_8k.htm">October
                                                                    3, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000095014225002895/eh250701813_8k.htm">November 5, 2025</A>
                                                                    and <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000162828025051032/rrgb-20251110.htm">November 10, 2025</A> (other than information in such Current Reports deemed to have been furnished and not filed in accordance with
                                                                    the rules of the SEC); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>the description of our capital stock set forth in our Registration Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000101706202001385/d8a12g.txt">Form&nbsp;8&#45;A</A> as filed with the SEC on July&nbsp;16,
2002, as supplemented and updated by the description of our capital stock set forth in <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175920000008/rrgb-20191229xex42.htm">Exhibit 4.2</A> to our Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175920000008/rrgb-20191229x10xk.htm">Form 10-K</A> filed
with the SEC on February 25, 2020, including any amendment or report filed with the SEC for the purpose of updating that description.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">All reports and other documents that we subsequently
file with the SEC (other than any portion of such filings that are furnished under applicable SEC rules rather than filed) pursuant to
Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus supplement and before the later of (1)&nbsp;the
completion of the offering of the securities described in this prospectus supplement and (2)&nbsp;the date we stop offering securities
pursuant to this prospectus supplement, will be deemed to be incorporated by reference into this prospectus supplement and to be part
of this prospectus supplement from the date of filing of such reports and documents. The information contained on our website (<I>www.redrobin.com</I>)
is not incorporated into this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">You should not assume that the information in
this prospectus supplement, the accompanying prospectus or any document incorporated by reference is accurate as of any date other than
the date of the applicable document. Any statement contained in a document incorporated or deemed to be incorporated by reference into
this prospectus supplement will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a
statement contained in this or any prospectus supplement, or any other subsequently filed document that is deemed to be incorporated by
reference into this prospectus supplement modifies or supersedes the statement. Any statement so modified or superseded will not be deemed,
except as so modified or superseded, to constitute a part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">You may request a copy of any or all documents
referred to above that have been or may be incorporated by reference into this prospectus (excluding certain exhibits to the documents)
at no cost, by writing or calling us at the following address or telephone number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Red Robin Gourmet Burgers,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Attention: Chief Legal Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">10000 E. Geddes Avenue, Suite 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Englewood, CO 80112</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">Telephone: (303)&nbsp;846&#45;6000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>



<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="ps_004"></A><B>FORWARD&#45;LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This prospectus supplement and the documents
incorporated by reference herein contain &ldquo;forward-looking statements&rdquo; within the meaning of the U.S. Private Securities Litigation
Reform Act of 1995, which involve risks and uncertainties. All statements other than statements of historical facts contained or incorporated
by reference in this prospectus supplement, including statements regarding our strategy, future operations, future financial position,
future revenue, projected costs, prospects, plans, objectives of management, and expected market growth are forward-looking statements.
These forward-looking statements are contained principally in the sections entitled &ldquo;Summary,&rdquo; &ldquo;Risk Factors&rdquo;
and &ldquo;Use of Proceeds,&rdquo; and in the documents incorporated by reference herein. Without limiting the generality of the preceding
sentence, any time we use the words &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;will,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo;
&ldquo;confident,&rdquo; &ldquo;continue,&rdquo; &ldquo;propose,&rdquo; &ldquo;seeks,&rdquo; &ldquo;could,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;forecasts,&rdquo; &ldquo;might,&rdquo; &ldquo;goals,&rdquo; &ldquo;objectives,&rdquo; &ldquo;targets,&rdquo;
&ldquo;planned,&rdquo; &ldquo;projects,&rdquo; and, in each case, their negative or other various or comparable terminology, and similar
expressions, we intend to clearly express that the information deals with possible future events and is forward-looking in nature. However,
the absence of these words or similar expressions does not mean that a statement is not forward-looking. For Red Robin, particular uncertainties
that could cause our actual results to be materially different than those expressed in our forward-looking statements include, without
limitation:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>the effectiveness of our strategic initiatives, including our &ldquo;First Choice&rdquo; plan, labor and service models, and operational
improvement initiatives and our ability to execute on such strategic initiatives;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>the global and domestic economic and geopolitical environment including tariffs and other trade barriers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>our ability to effectively compete in the industry and attract and retain Guests;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>the adequacy of cash flows and the cost and availability of capital or credit facility borrowings;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>our ability to service our debt and comply with the covenants in our credit facility;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>our ability to extend or refinance maturing indebtedness;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>a privacy or security breach or a failure of our information technology systems;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>the effectiveness and timing of our marketing and branding strategies and impact on reputation, including our loyalty programs and
social media platforms;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>changes in consumer preferences;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>leasing space including the location of such leases in areas of declining traffic;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>changes in cost and availability of commodities and the uncertain impact of tariffs or other potential disruptions in the supply chain;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>interruptions in the delivery of food and other products from third parties;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>pricing increases and labor costs;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>changes in consumer behavior or preference;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>aging technology infrastructure;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>expanding our restaurant base;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>maintaining and improving our existing restaurants;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>potential acquisitions or refranchising of our restaurants;</TD></TR></TABLE>





<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>our geographic concentration in the Western United States;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>the transition and retention of our key personnel;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>our ability to recruit, staff, train, and retain our workforce;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>operating conditions, including adverse weather conditions, natural disasters, pandemics and other events affecting the regions where
our restaurants are operated;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>actions taken by our franchisees that could harm our business or reputation;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>negative publicity regarding food safety or health concerns;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>protection of our intellectual property rights;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>changes in federal, state, or local laws and regulations affecting the operation of our restaurants;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>an increase in litigation or legal claims by Team Members, franchisees, customers, vendors, stockholders and others; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD>other risks, including the Risk Factors described from time to time in our filings with the SEC, including our Annual Report on Form
10-K for the fiscal year ended December 29, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">These forward-looking statements reflect our
views with respect to future events as of the date of this prospectus supplement and are based on assumptions and subject to risks and
uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking
statements represent our estimates and assumptions only as of the date of this prospectus supplement and, except as required by law, we
undertake no obligation to update or review publicly any forward-looking statements, whether as a result of new information, future events
or otherwise after the date of this prospectus supplement. We anticipate that subsequent events and developments will cause our views
to change. You should read this prospectus supplement, the accompanying prospectus and the documents filed as exhibits to the registration
statement, of which this prospectus supplement is a part, completely and with the understanding that our actual future results may be
materially different from what we expect. Our forward-looking statements do not reflect the potential impact of any future acquisitions,
merger, dispositions, joint ventures or investments we may undertake. We qualify all of our forward-looking statements by these cautionary
statements.</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<DIV STYLE="padding: 5pt; border: Black 1px solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="ps_005"></A>PROSPECTUS SUPPLEMENT SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><I>This summary does not contain all the information
that you should consider before investing in the securities offered by this prospectus supplement. Before making an investment decision,
you should carefully read the entire prospectus supplement and the accompanying prospectus, including the &#8220;Risk Factors&#8221; sections,
as well as the financial statements and the other information incorporated by reference herein and the information in any free writing
prospectus that we may authorize for use in connection with this offering.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Overview</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Red Robin Gourmet Burgers, Inc., together with
its subsidiaries, primarily operates, franchises, and develops casual dining restaurants in North America famous for serving more than
20 craveable, high-quality burgers with Bottomless Steak Fries&reg; and sides in a fun environment welcoming to Guests of all ages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We opened the first Red Robin restaurant in
Seattle, Washington in September 1969. In 1979, the first franchised Red Robin restaurant was opened in Yakima, Washington. In 2001, we
formed Red Robin Gourmet Burgers, Inc., a Delaware corporation, and consummated a reorganization of the Company. Since that time, Red
Robin Gourmet Burgers, Inc. has owned, either directly or indirectly, all of the outstanding capital stock or membership interests, respectively,
of Red Robin International, Inc. and our other operating subsidiaries through which we operate our Company-owned restaurants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As of October 5, 2025, we owned and operated
390 restaurants located in 39 states. We also had 90 franchised restaurants in 13 states and one Canadian province.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">For a description of our business, financial
condition, results of operations and other important information regarding us, see our filings with the SEC incorporated by reference
in this prospectus supplement. For instructions on how to find copies of the filings incorporated by reference in this prospectus supplement,
see &ldquo;<I>Where You Can Find More Information</I>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-indent: 0.5in">We were incorporated in Delaware under
the name Red Robin Gourmet Burgers,&nbsp;Inc. in 2001. Our principal executive office is located at 10000 E. Geddes Avenue, Suite 500,
Englewood, CO 80112, telephone (303) 846-6000. Our website address is <I>www.redrobin.com</I>. The information contained in, and that
can be accessed through, our website is not incorporated into and does not form&nbsp;a part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><I>Fourth Amendment to Credit Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-indent: 0.5in">On November 7, 2025, the Company entered
into an amendment to its Credit Agreement (the &ldquo;Fourth Amendment&rdquo;), by and among the Company, Red Robin International, Inc.,
as the borrower (the &ldquo;Borrower&rdquo;), certain subsidiary guarantors party thereto, certain lenders party thereto and Fortress
Credit Corp., as administrative agent and as collateral agent (the &ldquo;Agent&rdquo;), which amends the Credit Agreement, dated as
of March 4, 2022 (as amended by that certain First Amendment, dated as of July 17, 2023, that certain Second Amendment, dated as of August
21, 2024, that certain Third Amendment, dated as of November 4, 2024, the &ldquo;Credit Agreement&rdquo;, and by the Fourth Amendment,
the &ldquo;Amended Credit Agreement&rdquo;), by and among the Company, the Borrower, the lenders and issuing banks from time to time
party thereto, the Agent and the other parties from time to time party thereto. The Fourth Amendment extended the maturity dates for
the term loans and revolving credit facilities under the Credit Agreement by six months, from March 4, 2027 to September 3, 2027.&nbsp;</P>
</DIV>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<DIV STYLE="padding: 5pt; border: Black 1px solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>THE OFFERING</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 50%; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Red Robin Gourmet Burgers,&nbsp;Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock offered by us</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock having an aggregate offering price of up to $40,000,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock to be outstanding following this offering</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 26,494,785 shares of Common Stock, assuming sales of 8,528,785 shares
of Common Stock in this offering at an offering price of $4.69 per share, which was the last reported sale price of our Common Stock on
the Nasdaq Global Select Market on November 7, 2025. The actual number of shares issued will vary depending on the sales price under this
offering.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner of offering</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;At the market offering&#8221; that may be made from time to time through or to, Evercore, as sales agent. See &#8220;<I>Plan of Distribution</I>.&#8221;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<DIV STYLE="padding: 5pt; border: Black 1px solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 50%; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 50%">We intend to use the net proceeds from the sale of shares of our Common
Stock to strengthen our balance sheet, which could include use for working capital, general corporate purposes, and repayment of indebtedness.
We retain broad discretion over the use of the net proceeds from the sale of the shares of Common Stock offered hereby. See &ldquo;<I>Use
of Proceeds</I>.&rdquo;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing in our securities involves a high degree of risk. See &#8220;<I>Risk Factors</I>&#8221; beginning on page&nbsp;S&#45;4 of this prospectus supplement and in the documents incorporated by reference herein.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Global Select Market symbol</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RRGB.&#8221;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The number of shares of Common Stock to be outstanding
immediately after this offering is based on 17,966,000 shares of our Common Stock outstanding as of October 5, 2025. Unless otherwise
indicated, the number of shares of Common Stock presented in this prospectus supplement excludes:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>2,863,310 shares of Common Stock issuable upon the settlement of outstanding performance stock units and restricted stock units;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>106,428 shares of Common Stock issuable under our 2024 Performance Incentive Plan; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>121,269 shares of Common Stock issuable under our Employee Stock
Purchase Plan.</TD>
</TR></TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="ps_006"></A>RISK FACTORS</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><I>Investing in our securities involves a high degree
of risk. You should carefully consider the risks described below, as well as any amendment or update to our risk factors reflected in
subsequent filings with the SEC, which are incorporated by reference in this prospectus supplement, and all other information contained
in this prospectus supplement and the accompanying prospectus and incorporated by reference in this prospectus supplement and the accompanying
prospectus, and in any free writing prospectus that we have authorized for use in connection with this offering, before purchasing shares
of our Common Stock. These risks and uncertainties are not the only ones facing us. Additional risks and uncertainties that we are unaware
of, or that we currently deem immaterial, also may become important factors that affect us. If any of such risks or the risks described
below or in our SEC filings occur, our business, financial condition or results of operations could be materially and adversely affected.
In that case, the trading price of our Common Stock could decline, and you may lose some or all of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Risks Related to this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B><I>Management will have broad discretion as to the use of the
proceeds from this offering, and such uses may not improve our financial condition or market value.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: left; text-indent: 22.5pt">Because we have not designated
the amount of net proceeds from this offering to be used for any particular purpose, our management will have broad discretion as to the
application of the net proceeds from this offering and could use them for purposes other than those contemplated at the time of the offering.
Our management may use the net proceeds for corporate purposes that may not improve our financial condition or market value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>You may experience immediate and substantial dilution in the net
tangible book value per share of the Common Stock you purchase.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: left; text-indent: 22.5pt">The offering price per share
in this offering may exceed the net tangible book value per share of our Common Stock outstanding prior to this offering. Assuming that
an aggregate of 8,528,785 shares of our Common Stock are sold at a price of $4.69 per share pursuant to this prospectus supplement, which
was the last reported sale price of our Common Stock on the Nasdaq Global Select Market on November 7, 2025, for aggregate gross proceeds
of $40.0 million, after deducting commissions and estimated aggregate offering expenses payable by us, you would experience immediate
dilution of $7.17 per share, representing the difference between our as adjusted net tangible book value per share as of October 5, 2025
after giving effect to this offering and the assumed offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>You may experience future dilution as a result of future equity
offerings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 22.5pt">In order to raise additional
capital, we may in the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our
Common Stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any
other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing
shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional
shares of our Common Stock, or securities convertible or exchangeable into Common Stock, in future transactions may be higher or lower
than the price per share paid by investors in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 22.5pt">In addition, the sale
of shares in this offering and any future sales of a substantial number of shares of our Common Stock in the public market, or the perception
that such sales may occur, could adversely affect the price of our Common Stock. We cannot predict the effect, if any, that market sales
of those shares of Common Stock, or the perception that those shares may be sold, will have on the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>We plan to sell shares of our Common Stock in &ldquo;at the
market offerings&rdquo; and investors who buy shares of our Common Stock at different times will likely pay different prices.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 22.5pt">Investors who purchase
shares of our Common Stock in this offering at different times will likely pay different prices and may experience different outcomes
in their investment results. We will have discretion, subject to the effect of market conditions, to vary the timing, prices, and numbers
of shares sold in this offering. Investors may experience a decline in the value of their shares of our Common Stock. Many factors could
have an impact on the market price of our Common Stock, including the factors described above and in the accompanying prospectus and those
disclosed under &ldquo;<I>Risk Factors</I>&rdquo; in our 2024 Annual Report as updated in subsequent reports filed with the SEC.</P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B><I>The actual number of shares of Common Stock we will issue under
the distribution agreement, at any one time or in total, is uncertain.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 22.5pt">Subject to certain limitations
in the distribution agreement and compliance with applicable law, we have the discretion to deliver a placement notice to Evercore at
any time throughout the term of the distribution agreement. The number of shares of Common Stock that are sold by Evercore after delivering
a placement notice will fluctuate based on the market price of the shares of Common Stock during the sales period and limits we set with
Evercore. Because the price per share of each share sold will fluctuate based on the market price of our common stock during the sales
period, it is not possible at this stage to predict the number of shares of Common Stock that will be ultimately issued, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B><I>We do not expect to pay any dividends
in the foreseeable future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 22.5pt">In the past, we have not
paid dividends on our Common Stock. We do not currently intend to pay dividends on our Common Stock and we intend to retain our future
earnings, if any, to fund the development and growth of our business. In addition, the terms of certain existing and any future debt agreements
may preclude us from paying dividends. As a result, capital appreciation, if any, of our Common Stock may be your sole source of gain
for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Risks Related to Our Indebtedness</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: left; text-indent: 22.5pt"><B><I>Our ability to extend
or refinance maturing indebtedness is uncertain and could materially affect our liquidity, financial condition, and operations.&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: left; text-indent: 22.5pt">The Fourth Amendment extended
the maturity dates for our term loans and revolving credit facility by six months, from March 4, 2027 to September 3, 2027, and we are
actively working to secure long-term refinancing for our significant total borrowings, which was approximately $177.7 million as of October
5, 2025. However, we may not be able to obtain any further extensions or refinancings on acceptable terms or at all. Our ability to secure
additional extensions or to refinance maturing indebtedness depends on our future cash flows, financial performance, compliance with the
covenants in our credit facility, lender consent, and prevailing credit market conditions. If we cannot extend or refinance the indebtedness
when due, our lenders could accelerate repayment, and we may be required to repay the debt, sell assets, seek alternative financing on
unfavorable terms, or pursue other actions that could harm our liquidity and operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="ps_007"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We may issue and sell shares of our Common Stock
having aggregate sales proceeds of up to $40,000,000 from time to time. Because there is no minimum offering amount required as a condition
to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this
time. There can be no assurance that we will sell any shares under or fully utilize the distribution agreement with Evercore as a source
of financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We intend to use the net proceeds from the sale
of shares of our Common Stock to strengthen our balance sheet, which could include use for working capital, general corporate purposes,
and repayment of indebtedness. We retain broad discretion over the use of the net proceeds from the sale of the shares of Common Stock
offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="ps_008"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If you purchase shares of our Common Stock in
this offering, your interest will be diluted to the extent of the difference between the public offering price per share and the net tangible
book value per share of our Common Stock after this offering. We calculate net tangible book value per share by dividing our net tangible
assets (tangible assets less total liabilities) by the number of shares of our Common Stock issued and outstanding as of October 5, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">After giving effect to the sale by us of our
Common Stock in the aggregate amount of $40.0 million in this offering at an assumed offering price of $4.69 per share, which was the
last reported sale price of our Common Stock on the Nasdaq Global Select Market on November 7, 2025, and after deducting commissions and
estimated offering expenses payable by us, our adjusted net tangible book value as of October 5, 2025 would have been approximately $(65.7)&nbsp;million,
or $(2.48) per share of Common Stock. This amount represents an immediate increase in net tangible book value of $3.40 per share to existing
stockholders and an immediate dilution of $7.17 per share to purchasers in this offering. The following table illustrates the dilution:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD STYLE="width: 72%; text-indent: -10pt; padding-left: 10pt">Assumed public offering price per share</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%">$</TD>
    <TD STYLE="text-align: right; width: 10%">4.69</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">Net tangible book value per share as of October 5, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(5.88</TD><TD STYLE="text-align: left">)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Increase per share attributable to new investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.40</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">As adjusted net tangible book value per share as of October 5, 2025, after giving effect to this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right">(2.48</TD>
    <TD>)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Dilution per share to new investors purchasing shares in this offering</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double">$</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7.17</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD></TR>
  </TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The table above assumes, for illustrative purposes,
that an aggregate of 8,528,785 shares of our Common Stock are sold at a price of $4.69 per share, the last reported sale price of our
Common Stock on the Nasdaq Global Select Market on November 7, 2025, for aggregate gross proceeds of $40.0 million. The shares sold in
this offering, if any, will be sold from time to time at various prices. An increase of $1.00 per share in the price at which the shares
are sold from the assumed offering price to $4.69 per share shown in the table above, assuming all of our Common Stock in the aggregate
amount of $40.0 million during the term of the distribution agreement is sold at that price, would decrease our as adjusted net tangible
book value per share after the offering to $(2.63) per share and would increase the dilution in net tangible book value per share to new
investors to $8.32 per share, after deducting commissions and estimated aggregate offering expenses payable by us. A decrease of $1.00
per share in the price at which the shares are sold from the assumed offering price of $4.69 per share shown in the table above, assuming
all of our Common Stock in the aggregate amount of $40.0 million during the term of the distribution agreement is sold at that price,
would increase our as adjusted net tangible book value per share after the offering to $(2.28) per share and would decrease the dilution
in net tangible book value per share to new investors to $5.97 per share, after deducting commissions and estimated aggregate offering
expenses payable by us. This information is supplied for illustrative purposes only and may differ based on the actual offering price
and the actual number of shares offered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The number of shares of Common Stock expected
to be outstanding after this offering included in the table above are based on 17,966,000 shares of Common Stock outstanding, reflective
of the outstanding shares of Common Stock as of October 5, 2025 and excludes:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>2,863,310 shares of Common Stock issuable upon the settlement of outstanding performance stock units and restricted stock units;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>106,428 shares of Common Stock issuable under our 2024 Performance Incentive Plan; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>121,269 shares of Common Stock issuable under our Employee Stock Purchase Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">To the extent that other shares are issued,
investors purchasing shares in this offering could experience further dilution. In addition, we may choose to raise additional capital
due to market conditions or strategic considerations, even if we believe we have sufficient funds for our current or future operating
plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of those
securities could result in further dilution to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="ps_009"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We have entered into a distribution agreement,
which we refer to in this section as the &ldquo;Distribution Agreement,&rdquo; with Evercore Group L.L.C., which we refer to in this section
as the &ldquo;Sales Agent,&rdquo; under which we may offer and sell shares of our Common Stock having an aggregate gross sales price of
up to $40.0&nbsp;million from time to time through the Sales Agent. Sales of the shares of Common Stock, if any, may be made in transactions
that are deemed to be &ldquo;at the market offerings,&rdquo; as defined in Rule&nbsp;415(a)(4) promulgated under the Securities Act, including
sales made by means of ordinary brokers&rsquo; transactions on the Nasdaq Global Select Market or into any other existing trading market
for our Common Stock at market prices and such other sales as agreed upon by us and the Sales Agent. A copy of the Distribution Agreement
will be filed as an exhibit to a current report on Form&nbsp;8-K and is incorporated by reference in this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">When requested by us, the Sales Agent will offer
the shares of Common Stock subject to the terms and conditions of the Distribution Agreement, which may be on a daily basis for periods
of time, or as we may otherwise agree with the Sales Agent. We will designate the maximum number of shares of Common Stock to be sold
through the Sales Agent when we request it to do so. The Sales Agent has agreed, subject to the terms and conditions of the Distribution
Agreement, to use its commercially reasonable efforts to execute our orders to sell, as our agent and on our behalf, shares of our Common
Stock submitted to the Sales Agent from time to time by us, consistent with its normal sales and trading practices. We may instruct the
Sales Agent not to place shares of Common Stock at or below a price designated by us. In any event, the shares of Common Stock shall be
placed by the Sales Agent substantially at market price. We or the Sales Agent may suspend the offering of shares of Common Stock under
the Distribution Agreement upon proper notice to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We will pay the Sales Agent a commission of
up to 3% of the gross proceeds of any shares sold pursuant to this prospectus supplement, and reimburse the Sales Agent its expenses,
including fees and disbursements to its legal counsel, in an amount up to $150,000, in addition to certain ongoing disbursements up to
$15,000 per calendar quarter as described in the Distribution Agreement. The estimated offering expenses payable by us, in addition to
such commission and expenses, are approximately $400,000, which includes legal, accounting and printing costs and various other fees associated
with registering the shares of Common Stock. The remaining sale proceeds, after deducting any other transaction fees, will equal our net
proceeds from the sale of such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The Sales Agent will provide written confirmation
to us before the open on the Nasdaq Global Select Market on the day following each day on which shares of Common Stock are sold under
the Distribution Agreement. Each confirmation will include the number of shares sold on that day, the aggregate gross proceeds of such
sales and the net proceeds to us. Settlement for sales of shares of Common Stock will generally occur, unless otherwise agreed, on the
second trading day for the Nasdaq Global Select Market following the date on which such sales were made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We will report in a prospectus supplement and/or
our filings with the SEC under the Exchange Act at least quarterly the number of shares of our Common Stock sold through the Sales Agent
under the Distribution Agreement and the net proceeds to us and the compensation paid by us to the Sales Agent in connection with the
sales of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In connection with the sale of our Common Stock
on our behalf, the Sales Agent will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act and the compensation
of the Sales Agent will be deemed to be underwriting commissions or discounts. We have agreed to indemnify the Sales Agent against certain
liabilities, including liabilities under the Securities Act. We have also agreed to contribute to payments the Sales Agent may be required
to make in respect of such liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The Sales Agent and its affiliates have engaged
in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our
affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In addition, in the ordinary course of their
business activities, the Sales Agent and its affiliates may make or hold a broad array of investments and actively trade debt and equity
securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts
of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The
Sales Agent and its affiliates may also make investment recommendations and/or publish or express independent research views in respect
of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such
securities and instruments.</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">If either the Sales Agent or we have reason to believe that the exemptive
provisions set forth in Rule&nbsp;101(c)(1) of Regulation&nbsp;M under the Exchange Act are not satisfied, that party will promptly notify
the other and sales of our Common</P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-indent: 0pt">Stock under the Distribution Agreement will
be suspended until that or other exemptive provisions have been satisfied in the judgment of the Sales Agent and us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The offering of our Common Stock pursuant to
the Distribution Agreement will terminate upon the earlier of (i)&nbsp;the sale of all shares of our Common Stock subject to the Distribution
Agreement, (ii)&nbsp;the termination of the Distribution Agreement by us and/or by the Sales Agent and (iii)&nbsp;the third anniversary
of the effective date of the registration statement of which this prospectus forms&nbsp;a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This prospectus supplement in electronic format
may be made available on a website maintained by the Sales Agent, and the Sales Agent may distribute this prospectus supplement electronically.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="ps_010"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Certain legal matters in connection with the
offered securities will be passed upon for us by Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison&nbsp;LLP, New York, New York. Certain
legal matters will be passed upon for Evercore by Latham&nbsp;&amp; Watkins&nbsp;LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="ps_011"></A><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The consolidated financial statements of Red
Robin Gourmet Burgers, Inc. incorporated by reference in this prospectus, and the effectiveness of Red Robin Gourmet Burgers, Inc.&#8217;s
internal control over financial reporting have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting
firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm,
given their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; color: red"><B>The information in this prospectus is not complete
and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission
is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any
jurisdiction where the offer or sale is not permitted.</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center; color: red"><B>Subject to Completion, Dated
June 14, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><B>PROSPECTUS</B></P>


<P STYLE="font: 10pt Sans-Serif; margin: 0; text-align: center; color: Red"><IMG SRC="rrgb.jpg" ALT=""><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Red Robin Gourmet
Burgers, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>$75,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Debt Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Depositary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Purchase Contracts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may offer and sell from time to time shares
of our common stock, shares of our preferred stock, debt securities, depositary shares, warrants, rights, purchase contracts or&nbsp;units,
or any combination thereof, in one or more offerings in amounts, at prices and on terms that we determine at the time of the offering,
with an aggregate initial offering price of up to $75,000,000 (or its equivalent in foreign currencies, currency&nbsp;units or composite
currencies).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Each time we offer securities pursuant to this
prospectus, we will provide a prospectus supplement containing more information about the particular offering together with this prospectus.
The prospectus supplement also may add, update or change information contained in this prospectus. This prospectus may not be used to
offer and sell securities without a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">These securities may be sold on a continuous
or delayed basis directly to or through agents, dealers or underwriters as designated from time to time, or through a combination of these
methods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our common stock is traded on the Nasdaq Global
Select Market under the symbol &ldquo;RRGB.&rdquo; If we decide to list or seek a quotation for any other securities, the prospectus supplement
relating to those securities will disclose the exchange or market on which those securities will be listed or quoted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B>Investing in these securities involves significant
risks. We strongly recommend that you read carefully the risks we describe in this prospectus as well as in any accompanying prospectus
supplement and the risk factors that are incorporated by reference into this prospectus from our filings made with the Securities and
Exchange Commission. See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;<A HREF="#b_006">4</A>&nbsp;of this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">The date of this prospectus is&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;,
2024.</P>


<!-- Field: Page; Sequence: 16; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD STYLE="width: 88%"><FONT STYLE="font-size: 10pt"><A HREF="#b_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 12%; text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_002">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_003">INCORPORATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_004">FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_005">THE COMPANY</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_006">RISK FACTORS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_007">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_008">DESCRIPTION OF CAPITAL STOCK</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_009">DESCRIPTION OF THE DEBT SECURITIES</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_010">DESCRIPTION OF DEPOSITARY SHARES</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_011">DESCRIPTION OF THE WARRANTS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_012">DESCRIPTION OF THE RIGHTS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_013">DESCRIPTION OF THE PURCHASE CONTRACTS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_014">DESCRIPTION OF THE UNITS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_015">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_016">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(198,244,249)">
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#b_017">EXPERTS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-size: 10pt">29</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="b_001"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">To understand the terms of the securities offered
by this prospectus, you should carefully read this prospectus and any applicable prospectus supplement. You should also read the documents
referred to under the heading &ldquo;Where You Can Find More Information&rdquo; for information on us and the business conducted by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">This prospectus is part of a registration statement
that we filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;), using a &ldquo;shelf&rdquo; registration process. Under
this shelf registration process, we may offer and sell from time to time shares of our common stock, shares of our preferred stock, debt
securities, depositary shares, warrants, rights, purchase contracts or&nbsp;units, or any combination thereof, in one or more offerings
in amounts, at prices and on terms that we determine at the time of the offering, with an aggregate initial offering price of up to $75,000,000
(or its equivalent in foreign currencies, currency&nbsp;units or composite currencies). This prospectus provides you with a general description
of the securities. Each time we offer the securities, we will provide a prospectus supplement that describes the terms of the offering.
The prospectus supplement also may add, update or change information contained in this prospectus. Before making an investment decision,
you should read carefully both this prospectus and any prospectus supplement together with the documents incorporated by reference into
this prospectus as described below under the heading &ldquo;Incorporation by Reference.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The registration statement that contains this
prospectus, including the exhibits to the registration statement and the information incorporated by reference, provides additional information
about us and our securities. That registration statement can be found on the SEC&rsquo;s website at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">You should rely only on the information provided
in the registration statement, this prospectus and in any prospectus supplement, including the information incorporated by reference.
We have not authorized anyone to provide you with different information. You should not assume that the information in this prospectus
or any supplement to this prospectus is accurate at any date other than the date indicated on the cover page of these documents. We are
not making an offer to sell the securities in any jurisdiction where the offer or sale is not permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may sell the securities to or through underwriters,
dealers or agents or directly to purchasers. The securities may be sold for U.S. dollars, foreign-denominated currency, currency&nbsp;units
or composite currencies. Amounts payable with respect to any securities may be payable in U.S. dollars or foreign-denominated currency,
currency&nbsp;units or composite currencies as specified in the applicable prospectus supplement. We and our agents reserve the sole right
to accept or reject in whole or in part any proposed purchase of the securities. The prospectus supplement, which we will provide each
time we offer the securities, will set forth the names of any underwriters, dealers or agents involved in the sale of the securities,
and any related fee, commission or discount arrangements. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The prospectus supplement may also contain information
about any material U.S. federal income tax considerations relating to the securities covered by the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In this prospectus, the terms &ldquo;Red Robin,&rdquo;
&ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Red Robin Gourmet Burgers, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="b_002"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">As required by the Securities Act, we filed
a registration statement relating to the securities offered by this prospectus with the SEC. This prospectus is a part of that registration
statement, which includes additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We are subject to the reporting
requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and are required to file with the
SEC annual, quarterly and current reports, proxy statements and other information. Such reports include our audited financial
statements. Our publicly available filings can be found on the SEC&rsquo;s website at www.sec.gov. Our filings, including the
audited financial and additional information that we have made public to investors, may also be found on our website at
www.redrobin.com. Information on or accessible through our website does not constitute part of this prospectus (except for SEC
reports expressly incorporated by reference herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">As permitted by SEC rules, this prospectus does
not contain all of the information we have included in the registration statement and the accompanying exhibits and schedules we file
with the SEC. You may refer to the registration statement, exhibits and schedules for more information about us and the securities. The
registration statement, exhibits and schedules are available through the SEC&rsquo;s website.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_003"></A>INCORPORATION BY REFERENCE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
the information we file with the SEC, which means that we can disclose important information to you by referring you to those documents.
The information incorporated by reference is considered to be part of this prospectus. Information that we file later with the SEC will
automatically update and supersede information in this prospectus. In all cases, you should rely on the later information over different
information included in this prospectus or the prospectus supplement. The following documents have been filed by us with the SEC and are
incorporated by reference into this prospectus:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175924000011/rrgb-20231231.htm">our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2023, filed with the SEC on February&nbsp;28, 2024</A>;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175924000020/rrgb-20240421.htm">our Quarterly Report on Form 10-Q for the quarter ended April&nbsp;21, 2024, filed with the SEC on May&nbsp;29, 2024</A>;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">our Current Reports on Form 8-K filed with the SEC on&nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000117175924000004/rrgb-20240124.htm">January&nbsp;25, 2024</A>&nbsp;and&nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000110465924065579/tm2415665d1_8k.htm">May&nbsp;28, 2024</A>; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1171759/000101706202001385/d8a12g.txt">the description of Red Robin&rsquo;s capital stock set forth in Registration Statement on Form 8-A as filed with the SEC on July&nbsp;16, 2002, and any amendment or report filed with the SEC for the purpose of updating that description</A>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">All reports and other documents that we subsequently
file with the SEC (other than any portion of such filings that are furnished under applicable SEC rules rather than filed) pursuant to
Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus and before the later of (1)&nbsp;the completion
of the offering of the securities described in this prospectus and any prospectus supplement and (2)&nbsp;the date we stop offering securities
pursuant to this prospectus and any prospectus supplement, will be deemed to be incorporated by reference into this prospectus and to
be part of this prospectus from the date of filing of such reports and documents. The information contained on our website (www.redrobin.com)
is not incorporated into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">You should not assume that the information in
this prospectus, the prospectus supplement, any applicable pricing supplement or any document incorporated by reference is accurate as
of any date other than the date of the applicable document. Any statement contained in a document incorporated or deemed to be incorporated
by reference into this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement
contained in this prospectus or any other subsequently filed document that is deemed to be incorporated by reference into this prospectus
modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded,
to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">You may request a copy of any or all documents
referred to above that have been or may be incorporated by reference into this prospectus (excluding certain exhibits to the documents)
at no cost, by writing or calling us at the following address or telephone number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Red Robin Gourmet Burgers, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Attention: Chief Legal Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">10000 E. Geddes Avenue, Suite 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Englewood, CO 80112</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Telephone: (303) 846-6000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"><BR STYLE="clear: both">
</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_004"></A>FORWARD-LOOKING STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">This prospectus and the documents incorporated
by reference herein contain &ldquo;forward-looking statements&rdquo; within the meaning of the U.S. Private Securities Litigation Reform
Act of 1995, which involve risks and uncertainties. All statements other than statements of historical facts contained or incorporated
by reference in this prospectus, including statements regarding our strategy, future operations, future financial position, future revenue,
projected costs, prospects, plans, objectives of management, and expected market growth are forward-looking statements. These forward-looking
statements are contained principally in the sections entitled &ldquo;Summary,&rdquo; &ldquo;Risk Factors&rdquo; and &ldquo;Use of Proceeds,&rdquo;
and in the documents incorporated by reference herein. Without limiting the generality of the preceding sentence, any time we use the
words &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;will,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;confident,&rdquo;
&ldquo;continue,&rdquo; &ldquo;propose,&rdquo; &ldquo;seeks,&rdquo; &ldquo;could,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;estimates,&rdquo;
&ldquo;forecasts,&rdquo; &ldquo;might,&rdquo; &ldquo;goals,&rdquo; &ldquo;objectives,&rdquo; &ldquo;targets,&rdquo; &ldquo;planned,&rdquo;
&ldquo;projects,&rdquo; and, in each case, their negative or other various or comparable terminology, and similar expressions, we intend
to clearly express that the information deals with possible future events and is forward-looking in nature. However, the absence of these
words or similar expressions does not mean that a statement is not forward-looking. For Red Robin, particular uncertainties that could
cause our actual results to be materially different than those expressed in our forward-looking statements include, without limitation:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the effectiveness of the Company&rsquo;s strategic initiatives, including our &ldquo;North Star&rdquo;
plan, labor and service models, and operational improvement initiatives and our ability to execute on such strategic initiatives;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the global and domestic economic and geopolitical environment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">our ability to effectively compete in the industry and attract and retain Guests;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the adequacy of cash flows and the cost and availability of capital or credit facility borrowings;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">a privacy or security breach or a failure of our information technology systems;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the effectiveness and timing of the Company&rsquo;s marketing and branding strategies, including our
loyalty programs and social media platforms;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">changes in consumer preferences;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">leasing space including the location of such leases in areas of declining traffic;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">changes in cost and availability of commodities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">interruptions in the delivery of food and other products from third parties;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">pricing increases and labor costs;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">changes in consumer behavior or preference;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">expanding our restaurant base;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">maintaining and improving our existing restaurants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the transition and retention of our key personnel;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">our ability to recruit, staff, train, and retain our workforce;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">operating conditions, including adverse weather conditions, natural disasters, pandemics and other events
affecting the regions where our restaurants are operated;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">actions taken by our franchisees that could harm our business or reputation;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">negative publicity regarding food safety or health concerns;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">protection of our intellectual property rights;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">changes in federal, state, or local laws and regulations affecting the operation of our restaurants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">an increase in litigation or legal claims by Team Members, franchisees, customers, vendors, stockholders
and others; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">other risks, including the Risk Factors described from time to time in our filings with the SEC, including
our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">These forward-looking statements reflect our
views with respect to future events as of the date of this prospectus and are based on assumptions and subject to risks and uncertainties.
Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements represent
our estimates and assumptions only as of the date of this prospectus and, except as required by law, we undertake no obligation to update
or review publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of
this prospectus. We anticipate that subsequent events and developments will cause our views to change. You should read this prospectus
and the documents filed as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding
that our actual future results may be materially different from what we expect. Our forward-looking statements do not reflect the potential
impact of any future acquisitions, merger, dispositions, joint ventures or investments we may undertake. We qualify all of our forward-looking
statements by these cautionary statements.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_005"></A>THE COMPANY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Red Robin Gourmet Burgers, Inc., a Delaware
corporation, together with its subsidiaries, primarily operates, franchises, and develops casual dining restaurants in North America famous
for serving more than two dozen craveable, high-quality burgers with Bottomless Steak Fries&reg;&nbsp;and sides in a fun environment welcoming
to Guests of all ages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We opened the first Red Robin restaurant in
Seattle, Washington in September&nbsp;1969. In 1979, the first franchised Red Robin restaurant was opened in Yakima, Washington. In 2001,
we formed Red Robin Gourmet Burgers, Inc., a Delaware corporation, and consummated a reorganization of the Company. Since that time, Red
Robin Gourmet Burgers, Inc. has owned, either directly or indirectly, all of the outstanding capital stock or membership interests, respectively,
of Red Robin International, Inc. and our other operating subsidiaries through which we operate our Company-owned restaurants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">For a description of our business, financial
condition, results of operations and other important information regarding Red Robin, we refer you to our filings with the SEC incorporated
by reference into this prospectus. For instructions on how to find copies of these documents, see &ldquo;Where You Can Find More Information.&rdquo;
More information about us is also available through our website at www.redrobin.com. The information on our website is not incorporated
by reference into this prospectus or any accompanying prospectus supplement (except for SEC reports that are expressly incorporated by
reference herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our principal executive offices are located
at 10000 E. Geddes Avenue, Suite 500, Englewood, CO 80112, telephone (303) 846-6000.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_006"></A>RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Investing in our securities involves risk. Before
you decide whether to purchase any of our securities, you should carefully consider the specific risks discussed in, or incorporated by
reference into, the applicable prospectus supplement, together with all the other information contained in the prospectus supplement or
incorporated by reference into this prospectus and the applicable prospectus supplement. You should also consider the risks, uncertainties
and assumptions discussed under the caption &ldquo;Risk Factors&rdquo; included in our most recent Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q, which are incorporated by reference into this prospectus. These risk factors may be amended, supplemented or superseded
from time to time by other reports we file with the SEC in the future. For more information, please see &ldquo;Where You Can Find More
Information&rdquo; and &ldquo;Incorporation by Reference.&rdquo; These risks could materially and adversely affect our business, results
of operations and financial condition and could result in a partial or complete loss of your investment.</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_007"></A>USE OF PROCEEDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Unless we specify another use in the applicable
prospectus supplement, we will use the net proceeds from the sale of the securities offered by us for general corporate purposes, which
may include, among other things:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">repurchases of shares of our common stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">debt repayment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">working capital; and/or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">capital expenditures.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may also use such proceeds to fund business
combinations, including acquisitions of businesses, technologies or product lines that complement our current business. We may set forth
additional information on the use of net proceeds from the sale of the securities we offer under this prospectus in a prospectus supplement
related to a specific offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_008"></A>DESCRIPTION OF CAPITAL STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">General</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The following is a summary of information concerning
our capital stock, including a summary of certain material terms and provisions of our certificate of incorporation and our by-laws. You
should read these documents in full for complete information on our capital stock. They are included as exhibits to the registration statement
of which this prospectus forms a part.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B><I>Shares Outstanding.</I></B>&nbsp;&nbsp;&nbsp;We
are authorized to issue up to 45,000,000 shares of common stock, par value $0.001 per share. As of June 12, 2024, we had 15,684,445 shares
of common stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B><I>Dividends.</I></B>&nbsp;&nbsp;&nbsp;Subject
to prior dividend rights of the holders of any preferred shares, holders of shares of our common stock are entitled to receive dividends
when, as and if declared by our board of directors out of funds legally available for that purpose. Delaware law allows a corporation
to pay dividends only out of surplus, as determined under Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B><I>Voting Rights.</I></B>&nbsp;&nbsp;&nbsp;Each
share of common stock is entitled to one vote on all matters submitted to a vote of stockholders. Holders of shares of our common stock
do not have cumulative voting rights. This means a holder of a single share of common stock cannot cast more than one vote for each position
to be filled on our board of directors. It also means the holders of a majority of the shares of common stock entitled to vote in the
election of directors can elect all directors standing for election and the holders of the remaining shares will not be able to elect
any directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B><I>Other Rights.</I></B>&nbsp;&nbsp;&nbsp;In
the event of any liquidation, dissolution or winding up of our company, after the satisfaction in full of the liquidation preferences
of holders of any preferred shares, holders of shares of our common stock are entitled to ratable distribution of the remaining assets
available for distribution to stockholders. The shares of our common stock are not subject to redemption by operation of a sinking fund
or otherwise. Holders of shares of our common stock have no preemptive, subscription, redemption or conversion rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B><I>Fully Paid.</I></B>&nbsp;&nbsp;&nbsp;The
issued and outstanding shares of our common stock are fully paid and non-assessable. This means the full purchase price for the outstanding
shares of our common stock has been paid and the holders of such shares will not be assessed any additional amounts for such shares. Any
additional shares of common stock that we may issue in the future will also be fully paid and non-assessable.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Preferred Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We are authorized to issue up to 3,000,000 shares
of preferred stock, par value $0.001 per share, from time to time in one or more series and with such rights and preferences as determined
by our board of directors with respect to each series. As of the date of this prospectus, no shares of our preferred stock are issued
and outstanding.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Limitation on Liability of Directors and Officers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We are a Delaware corporation. Our certificate
of incorporation provides that no director is personally liable to us or our stockholders for monetary damages for breach of fiduciary
duty as a director, except as required by applicable law, as in effect from time to time. Currently, Delaware law requires that liability
be imposed only for the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any breach of the director&rsquo;s duty of loyalty to our company or our stockholders;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any act or omission not in good faith or which involved intentional misconduct or a knowing violation
of law;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174
of the Delaware General Corporation Law; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any transaction from which the director derived an improper personal benefit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">As a result, neither we nor our stockholders
have the right, including through stockholders&rsquo; derivative suits on our behalf, to recover monetary damages against a director for
breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior, except in the situations described
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our certificate of incorporation provides that,
to the fullest extent permitted by law, we will indemnify any officer or director of our company in connection with any threatened, pending
or completed action, suit or proceeding to which such person is, or is threated to be made, a party, whether civil or criminal, administrative
or investigative, arising out of the fact that the person is or was our director or officer, or served any other enterprise at our request
as a director or officer. We will reimburse the expenses, including attorneys&rsquo; fees, incurred by a person indemnified by this provision
in connection with any proceeding, including in advance of its final disposition, to the fullest extent permitted by law. Amending this
provision will not reduce our indemnification obligations relating to actions taken before an amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We maintain insurance for our officers and directors
against certain liabilities, including liabilities under the Securities Act, under insurance policies, the premiums of which are paid
by us. The effect of these is to indemnify any officer or director of the Company against expenses, judgments, attorney&rsquo;s fees and
other amounts paid in settlements incurred by an officer or director arising from claims against such persons for conduct in their capacities
as officers or directors of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Anti-Takeover Effects of Our Certificate of Incorporation and
By-laws and Delaware Law</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Some provisions of our certificate of incorporation
and by-laws and Delaware law could make the following more difficult:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">acquisition of us by means of a tender offer;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">acquisition of us by means of a proxy contest or otherwise; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">removal of our incumbent officers and directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">These provisions, summarized below, are expected
to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking
to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection give us
the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us and outweigh
the disadvantages of discouraging those proposals because negotiation of them could result in an improvement of their terms.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">Size of Board and Vacancies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our by-laws provide that our board of directors
have one or more members, which number is determined by resolution of our board of directors. Directors are elected at each annual meeting
of stockholders by the vote of a majority of the shares present. Any director may be removed at any time, with or without cause, upon
the affirmative vote of holders of two-thirds our voting stock. Newly created directorships resulting from any increase in our authorized
number of directors or any vacancies in our board of directors resulting from death, resignation, retirement, removal from office or other
cause may be filled by the majority vote of our remaining directors in office, or by the sole remaining director, or by a majority vote
of our stockholders at an annual meeting of our stockholders.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">Elimination of Stockholder Action by Written Consent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our certificate of incorporation eliminates
the right of our stockholders to act by written consent. Stockholder action must take place at the annual or a special meeting of our
stockholders.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">Stockholder Meetings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Under our by-laws, only our chairman, chief
executive officer, our board of directors or holders of 10% or more of our voting stock, may call special meetings of our stockholders.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">Requirements for Advance Notification of Stockholder
Nominations and Proposals; Proxy Access</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our by-laws establish advance notice procedures
with respect to stockholder proposals and nomination of candidates for election as directors other than nominations made by or at the
direction of our board of directors or a committee of our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our bylaws provide that a stockholder, or a
group of up to 20 stockholders, owning at least three percent of the voting power of our outstanding capital stock continuously for at
least three years, may nominate and include in our annual meeting proxy materials director nominees constituting up to the greater of
(a) two directors or (b) twenty percent of the number of directors to be elected at such annual meeting, subject to certain limitations
and provided that the stockholders and nominees satisfy the requirements specified in our bylaws.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">Delaware Anti-Takeover Law</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We are subject to Section&nbsp;203 of the Delaware
General Corporation Law, an anti-takeover law. In general, Section&nbsp;203 prohibits a publicly held Delaware corporation from engaging
in a business combination with an interested stockholder for a period of three&nbsp;years following the date such person became an interested
stockholder, unless the business combination or the transaction in which such person became an interested stockholder is approved in a
prescribed manner. Generally, a &ldquo;business combination&rdquo; includes a merger, asset or stock sale, or other transaction resulting
in a financial benefit to the interested stockholder. Generally, an &ldquo;interested stockholder&rdquo; is a person that, together with
affiliates and associates, owns, or within three&nbsp;years prior to the determination of interested stockholder status did own, 15% or
more of a corporation&rsquo;s voting stock. The existence of this provision may have an anti-takeover effect with respect to transactions
not approved in advance by our board of directors, including discouraging attempts that might result in a premium over the market price
for the shares of our common stock.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">No Cumulative Voting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Neither our certificate of incorporation nor
our by-laws provide for cumulative voting in the election of directors.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">Undesignated Preferred Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The authorization of our undesignated preferred
stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede
the success of any attempt to change control of our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><B>Forum for Adjudication of Disputes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our certificate of incorporation provides that
unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and
exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting breach of a fiduciary duty owed by
any of our directors, officers or other employees, any action asserting a claim arising pursuant to the Delaware General Corporation Law
or any action asserting a claim governed by the internal affairs doctrine. Despite the foregoing, it is possible that a court could rule
that such provision is inapplicable or unenforceable. In addition, this provision would not affect the ability of our stockholders to
seek remedies under the federal securities laws.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Transfer Agent and Registrar</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our transfer agent and registrar is Equiniti
Trust Company, LLC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Listing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Our shares of common stock are listed on the
Nasdaq Global Select Market under the ticker symbol &ldquo;RRGB.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_009"></A>DESCRIPTION OF THE DEBT SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The following description of the terms of the
debt securities sets forth certain general terms and provisions of the debt securities to which any prospectus supplement may relate.
The particular terms of the debt securities offered by any prospectus supplement and the extent, if any, to which these general provisions
may apply to those debt securities will be described in the prospectus supplement relating to those debt securities. Accordingly, for
a description of the terms of a particular issue of debt securities, reference must be made to both the prospectus supplement relating
thereto and to the following description.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may issue debt securities from time to time
in one or more series. The debt securities will be general obligations of Red Robin Gourmet Burgers, Inc. The debt securities may be fully
and unconditionally guaranteed on a secured or unsecured senior or subordinated basis, jointly and severally, by guarantors, if any. In
the event that any series of debt securities will be subordinated to other indebtedness that we have outstanding or may incur, the terms
of the subordination will be set forth in the prospectus supplement relating to the subordinated debt securities. Debt securities will
be issued under one or more indentures between us and Computershare Trust Company, N.A., as trustee. A copy of the form of indenture has
been filed as an exhibit to the registration statement filed with the SEC. The following discussion of certain provisions of the indenture
is a summary only and should not be considered a complete description of the terms and provisions of the indenture. Accordingly, the following
discussion is qualified in its entirety by reference to the provisions of the indenture, including the definition of certain terms used
below. You should refer to the indenture for the complete terms of the debt securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">General</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The debt securities will represent direct, general
obligations of Red Robin Gourmet Burgers, Inc. and:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">may rank equally with other unsubordinated debt or may be subordinated to other debt we have or may
incur;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">may be issued in one or more series with the same or various maturities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">may be issued at a price of 100% of their principal amount or at a premium or discount;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">may be issued in registered or bearer form and certificated or uncertificated form; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">may be represented by one or more global debt securities registered in the name of a designated depositary&rsquo;s
nominee, and if so, beneficial interests in the global note will be shown on and transfers will be made only through records maintained
by the designated depositary and its participants.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The aggregate principal amount of debt securities
that we may authenticate and deliver is unlimited. Subject to limitations contained in the indenture, we may from time to time, without
notice to or the consent of the holders of a series of debt securities, issue additional debt securities of any such series on the same
terms and conditions as the debt securities of such series, except for any differences in the issue price and, if applicable, the initial
interest accrual date and interest payment date;&nbsp;<I>provided</I>&nbsp;that if the additional debt securities are not fungible with
the debt securities of such series for U.S. federal income tax purposes, such additional debt securities will have one or more separate
CUSIP numbers. You should refer to the applicable prospectus supplement for the following terms of the debt securities of the series with
respect to which that prospectus supplement is being delivered:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the title of the debt securities of the series (which will distinguish the debt securities of that particular
series from the debt securities of any other series) and ranking (including the terms of any subordination provisions);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the price or prices of the debt securities of the series at which such debt securities will be issued;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">whether the debt securities are entitled to the benefit of any guarantee by any guarantor;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any limit on the aggregate principal amount of the debt securities of the series that may be authenticated
and delivered under the indenture (except for debt securities authenticated and delivered upon registration or transfer of, or in exchange
for, or in lieu of, other debt securities of the series);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the date or dates on which the principal and premium with respect to the debt securities of the series
are payable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the person to whom any interest on a security of the series shall be payable if other than the person
in whose name that security is registered at the close of business on the record date;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the rate or rates (which may be fixed or variable) at which the debt securities of the series will bear
interest (if any) or the method of determining such rate or rates (including, but not limited to, any commodity, commodity index, stock
exchange index or financial index), the date or dates from which such interest, if any, will accrue, the interest payment dates on which
such interest, if any, will be payable or the method by which such dates will be determined, the record dates for the determination of
holders thereof to whom such interest is payable (in the case of securities in registered form), and the basis upon which interest will
be calculated if other than that of a 360-day year of twelve 30-day&nbsp;months;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the currency or currencies in which debt securities of the series will be denominated and/or in which
payment of the principal, premium, if any, and interest of any of the securities shall be payable, if other than U.S. dollars, the place
or places, if any, in addition to or instead of the corporate trust office of the trustee (in the case of securities in registered form)
where the principal, premium and interest, if any, with respect to debt securities of the series will be payable, where notices and demands
to or upon us in respect of the debt securities and the indenture may be delivered, and the method of such payment, if by wire transfer,
mail or other means;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the price or prices at which, the period or periods within which, and the terms and conditions upon
which debt securities of the series may be redeemed, in whole or in part, at our option or otherwise;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">whether debt securities of the series are to be issued as securities in registered form or securities
in bearer form or both and, if securities in bearer form are to be issued, whether coupons will be attached to them, whether securities
in bearer form of the series may be exchanged for securities in registered form of the series, and the circumstances under which and the
places at which any such exchanges, if permitted, may be made;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if any debt securities of the series are to be issued as securities in bearer form or as one or more
global securities representing individual securities in bearer form of the series, whether certain provisions for the payment of additional
interest or tax redemptions will apply; whether interest with respect to any portion of a temporary bearer security of the series payable
with respect to any interest payment date prior to the exchange of such temporary bearer security for definitive securities in bearer
form of the series will be paid to any clearing organization with respect to the portion of such temporary bearer security held for its
account and, in such event, the terms and conditions (including any certification requirements) upon which any such interest payment received
by a clearing organization will be credited to the persons entitled to interest payable on such interest payment date; and the terms upon
which a temporary bearer security may be exchanged for one or more definitive securities in bearer form of the series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the obligation or right, if any, to redeem, purchase or repay debt securities of the series pursuant
to any sinking fund or analogous provisions or at the option of a holder of such debt securities and the price or prices at which, the
period or periods within which, and the terms and conditions upon which, debt securities of the series will be redeemed, purchased or
repaid, in whole or in part, pursuant to such obligations;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the terms, if any, upon which the debt securities of the series may be convertible into or exchanged
for any issuer&rsquo;s common stock, preferred stock, depositary shares, other debt securities or warrants for common stock, preferred
stock, depositary shares, indebtedness or other securities of any kind and the terms and conditions upon which such conversion or exchange
will be effected, including the initial conversion or exchange price or rate, the conversion or exchange period and any other additional
provisions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if other than minimum denominations of $2,000 or any integral multiple of $1,000 in excess thereof,
the denominations in which debt securities of the series will be issuable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if the amount of principal, premium or interest with respect to the debt securities of the series may
be determined with reference to an index or pursuant to a formula, the manner in which such amounts will be determined;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if the principal amount payable at the stated maturity of debt securities of the series will not be
determinable as of any one or more dates prior to such stated maturity, the amount that will be deemed to be such principal amount as
of any such date for any purpose, including the principal amount thereof which will be due and payable upon any maturity other than the
stated maturity or which will be deemed to be outstanding as of any such date (or, in any such case, the manner in which such deemed principal
amount is to be determined), and if necessary, the manner of determining the equivalent thereof in U.S. dollars;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any changes or additions to the provisions of the indenture dealing with defeasance;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if other than the principal amount thereof, the portion of the principal amount of debt securities of
the series that will be payable upon declaration of acceleration of the maturity thereof or provable in bankruptcy;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the terms, if any, of the transfer, mortgage, pledge or assignment as security for the debt securities
of the series of any properties, assets, moneys, proceeds, securities or other collateral and any corresponding changes to provisions
of the indenture as then in effect;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any addition to or change in the events of default with respect to the debt securities of the series
and any change in the right of the trustee or the holders to declare the principal, premium and interest, if any, with respect to such
debt securities due and payable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if the debt securities of the series will be issued in whole or in part in the form of a global security,
the terms and conditions, if any, upon which such global security may be exchanged in whole or in part for other individual debt securities
in definitive registered form, the depositary (as defined in the applicable prospectus supplement) for such global security and the form
of any legend or legends to be borne by any such global security in addition to or in lieu of the legend referred to in the indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any trustee, authenticating or paying agent, transfer agent or registrar or any other agent with respect
to the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the applicability of, and any addition to, deletion of or change in, the covenants and definitions then
set forth in the indenture or in the terms then set forth in the indenture relating to permitted consolidations, mergers or sales of assets;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the terms, if any, of any guarantee of the payment of principal, premium and interest with respect to
debt securities of the series and any corresponding changes to the provisions of the indenture as then in effect;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the subordination, if any, of the debt securities of the series pursuant to the indenture and any changes
or additions to the provisions of the indenture relating to subordination;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">with regard to debt securities of the series that do not bear interest, the dates for certain required
reports to the trustee;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any provisions granting special rights to holders when a specified event occurs;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any co-issuers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the place or places where the principal of and interest, if any, on the debt securities will be payable,
where the debt securities may be surrendered for registration of transfer or exchange and where notices and demands to or upon us in respect
of the debt securities and the indenture may be served, and the method of such payment, if by wire transfer, mail or other means; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any other terms of the debt securities of the series (which terms will not be prohibited by the provisions
of the indenture).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The prospectus supplement will also describe
any material U.S. federal income tax consequences or other special considerations applicable to the series of debt securities to which
such prospectus supplement relates, including those applicable to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">securities in bearer form;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">debt securities with respect to which payments of principal, premium or interest are determined with
reference to an index or formula (including changes in prices of particular securities, currencies or commodities);</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">debt securities with respect to which principal or interest is payable in a foreign or composite currency;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">debt securities that are issued at a discount below their stated principal amount, bearing no interest
or interest at a rate that at the time of issuance is below market rates or original issue discount debt securities; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">variable rate debt securities that are exchangeable for fixed rate debt securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Unless otherwise provided in the applicable
prospectus supplement, securities in registered form may be transferred or exchanged at the office of the trustee at which its corporate
trust business is principally administered in the United States, subject to the limitations provided in the indenture, without the payment
of any service charge, other than any tax or governmental charge payable in connection therewith. Securities in bearer form will be transferable
only by delivery. Provisions with respect to the exchange of securities in bearer form will be described in the prospectus supplement
relating to those securities in bearer form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">All funds that we pay to a paying agent for
the payment of principal, premium or interest with respect to any debt securities that remain unclaimed at the end of two&nbsp;years after
that principal, premium or interest will have become due and payable will be repaid to us, and the holders of those debt securities or
any related coupons will thereafter look only to us for payment thereof.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Global Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The debt securities of a series may be issued
in whole or in part in the form of one or more global securities. A global security is a debt security that represents, and is denominated
in an amount equal to the aggregate principal amount of, all outstanding debt securities of a series, or any portion thereof, in either
case having the same terms, including the same original issue date, date or dates on which principal and interest are due, and interest
rate or method of determining interest. A global security will be deposited with, or on behalf of, a depositary, which will be identified
in the prospectus supplement relating to such debt securities. Global securities may be issued in either registered or bearer form and
in either temporary or definitive form. Unless and until it is exchanged in whole or in part for the individual debt securities represented
thereby, a global security may not be transferred except as a whole by the depositary to a nominee of the depositary, by a nominee of
the depositary to the depositary or another nominee of the depositary, or by the depositary or any nominee of the depositary to a successor
depositary or any nominee of such successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The terms of the depositary arrangement with
respect to a series of debt securities will be described in the prospectus supplement relating to such debt securities. We anticipate
that the following provisions will generally apply to depositary arrangements, in all cases subject to any restrictions or limitations
described in the prospectus supplement relating to such debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Upon the issuance of a global security, the
depositary for such global security will credit, on its book entry registration and transfer system, the respective principal amounts
of the individual debt securities represented by such global security to the accounts of persons that have accounts with the depositary.
Such accounts will be designated by the dealers or underwriters with respect to such debt securities or, if such debt securities are offered
and sold directly by us or through one or more agents, by us or such agents. Ownership of beneficial interests in a global security will
be limited to participants or persons that hold beneficial interests through participants. Ownership of beneficial interests in such global
security will be shown on, and the transfer of that ownership will be effected only through, records maintained by the depositary (with
respect to interests of participants) or records maintained by participants (with respect to interests of persons other than participants).
The laws of some states require that certain purchasers of securities take physical delivery of such securities in definitive form. Such
limitations and laws may impair the ability to transfer beneficial interests in a global security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">So long as the depositary for a global
security, or its nominee, is the registered owner or holder of such global security, such depositary or nominee, as the case may be,
will be considered the sole owner or holder of the individual debt securities represented by such global security for all purposes
under the indenture. Except as provided below, owners of beneficial interests in a global security will not be entitled to have any
of the individual debt securities represented by such global security registered in their names, will not receive</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">or be entitled to receive physical delivery of any of such debt
securities in definitive form and will not be considered the owners or holders thereof under the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Payments of principal, premium and interest
with respect to individual debt securities represented by a global security will be made to the depositary or its nominee, as the case
may be, as the registered owner or holder of such global security. Neither we, the trustee, any paying agent or registrar for such debt
securities nor any agent of ours or the trustee will have any responsibility or liability for:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any aspect of the records relating to or payments made by the depositary, its nominee or any participants
on account of beneficial interests in the global security or for maintaining, supervising or reviewing any records relating to such beneficial
interests;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the payment to the owners of beneficial interests in the global security of amounts paid to the depositary
or its nominee; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any other matter relating to the actions and practices of the depositary, its nominee or its participants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Neither we, the trustee, any paying agent or
registrar for such debt securities nor any agent of ours or the trustee will be liable for any delay by the depositary, its nominee or
any of its participants in identifying the owners of beneficial interests in the global security, and we and the trustee may conclusively
rely on, and will be protected in relying on, instructions from the depositary or its nominee for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We expect that the depositary for a series of
debt securities or its nominee, upon receipt of any payment of principal, premium or interest with respect to a definitive global security
representing any of such debt securities, will immediately credit participants&rsquo; accounts with payments in amounts proportionate
to their respective beneficial interests in the principal amount of such global security, as shown on the records of the depositary or
its nominee. We also expect that payments by participants to owners of beneficial interests in such global security held through such
participants will be governed by standing instructions and customary practices, as is now the case with securities held for the accounts
of customers and registered in &ldquo;street name.&rdquo; Such payments will be the responsibility of such participants. See &ldquo;&mdash;
Limitations on Issuance of Securities in Bearer Form&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">If the depositary for a series of debt securities
is at any time unwilling, unable or ineligible to continue as depositary, we will appoint a successor depositary. If a successor depositary
is not appointed by us within 90&nbsp;days, we will issue individual debt securities of such series in exchange for the global security
representing such series of debt securities. In addition, we may at any time and in our sole discretion determine to no longer have debt
securities of a series represented by a global security and, in such event, will issue individual debt securities of such series in exchange
for the global security representing such series of debt securities. Furthermore, if we so specify with respect to the debt securities
of a series, an owner of a beneficial interest in a global security representing debt securities of such series may, on terms acceptable
to us, the trustee and the depositary for such global security, receive individual debt securities of such series in exchange for such
beneficial interests. In any such instance, an owner of a beneficial interest in a global security will be entitled to physical delivery
of individual debt securities of the series represented by such global security equal in principal amount to such beneficial interest
and to have such debt securities registered in its name (if the debt securities are issuable as securities in registered form). Individual
debt securities of such series so issued generally will be issued:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">as securities in registered form in minimum denominations, unless otherwise specified by us, of $2,000
and any integral multiples of $1,000 in excess thereof if the debt securities are issuable as securities in registered form;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">as securities in bearer form in the denomination or denominations specified by us if the debt securities
are issuable as securities in bearer form; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">as either securities in registered form or securities in bearer form as described above if the debt
securities are issuable in either form.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Limitations on Issuance of Securities in Bearer Form</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The debt securities of a series may be issued
as securities in registered form (which will be registered as to principal and interest in the register maintained by the registrar for
such debt securities) or securities in</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">bearer form (which will be transferable only by delivery). If such
debt securities are issuable as securities in bearer form, the applicable prospectus supplement will describe certain special limitations
and considerations that will apply to such debt securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Certain Covenants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">If debt securities are issued, the indenture,
as supplemented for a particular series of debt securities, will contain certain covenants for the benefit of the holders of such series
of debt securities, which will be applicable (unless waived or amended) so long as any of the debt securities of such series are outstanding,
unless stated otherwise in the prospectus supplement. The specific terms of the covenants, and summaries thereof, will be set forth in
the prospectus supplement relating to such series of debt securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Subordination</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Debt securities of a series and any guarantees,
may be subordinated, which we refer to as subordinated debt securities, to senior indebtedness (as defined in the applicable prospectus
supplement) to the extent set forth in the prospectus supplement relating thereto. To the extent we conduct operations through subsidiaries,
the holders of debt securities (whether or not subordinated debt securities) will be structurally subordinated to the creditors of our
subsidiaries, except to the extent such subsidiary is a guarantor of such series of debt securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Events of Default</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Each of the following will constitute an event
of default under the form of indenture with respect to any series of debt securities:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">default in payment of the principal amount of the debt securities of that series, when such amount becomes
due and payable at maturity, upon acceleration, required redemption or otherwise;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">failure to pay interest on the debt securities of that series within 30&nbsp;days of the due date;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">failure to comply with the obligations described under &ldquo;&mdash; Mergers and Sales of Assets&rdquo;
below;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">failure to comply for 90&nbsp;days after notice with any of our other agreements in the debt securities
of that series or the indenture or supplemental indenture related to that series of debt securities; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">certain events of bankruptcy, insolvency or reorganization affecting us.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">A prospectus supplement may omit, modify or
add to the foregoing events of default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">An event of default under one series of debt
securities does not necessarily constitute an event of default under any other series of debt securities. A default under the fourth bullet
above will not constitute an event of default until the trustee or the holders of 30% in principal amount of the outstanding debt securities
of such series notify us of the default and we do not cure such default within the time specified after receipt of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">If any event of default (other than an
event of default relating to certain events of bankruptcy, insolvency or reorganization) occurs and is continuing with respect to a
particular series of debt securities, either the trustee or the holders of not less than 30% in aggregate principal amount of the
debt securities of that series then outstanding by written notice to us (and to the trustee if such notice is given by the holders),
may declare the principal amount of (or in the case of original issue discount debt securities, the portion thereby specified in the
terms thereof), and accrued interest on the debt securities of that series to be immediately due and payable. In the case of certain
events of bankruptcy, insolvency or reorganization, the principal amount of, and accrued interest on the debt securities of that
series will automatically become and be immediately due and payable without any declaration or other act on the part of the trustee
or any holders. Upon a declaration by the trustee or the holders, we will be obligated to pay the principal amount plus accrued and
unpaid interest of each affected series of debt securities so declared due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The holders of a majority in aggregate principal
amount of the debt securities of any series then outstanding by written notice to the trustee under the indenture may on behalf of the
holders of all of such series of debt securities waive any existing default or event of default and its consequences under the</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">applicable indenture except a continuing default or event of default
in the payment of interest on, or the principal of, the debt securities of such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Subject to the provisions of the indenture relating
to the duties of the trustee in case an event of default will occur and be continuing, the trustee is under no obligation to exercise
any of its rights or powers under the indenture or debt securities at the request or direction of any of the holders of any series of
debt securities, unless such holders have offered to the trustee indemnity or security satisfactory to the trustee against any fee, cost,
damage, claim, loss, liability or expense (including reasonable attorney&rsquo;s fees and expenses). Subject to such provisions for the
indemnification of the trustee, the holders of at least a majority in aggregate principal amount of the outstanding debt securities of
a series have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising
any trust or power conferred on the trustee with respect to such series of debt securities. The trustee, however, may refuse to follow
any direction that conflicts with law or the indenture or that the trustee determines is unduly prejudicial to the rights of any other
holder of such series of debt securities (it being understood that the trustee does not have an affirmative duty to ascertain whether
or not such direction is unduly prejudicial to the rights of any such other holder) or that would involve the trustee in personal liability.
Prior to taking any action under the indenture, the trustee is entitled to indemnification satisfactory to it in its sole discretion against
all fees, claims, damages, costs, loss, liability and expense (including reasonable attorney&rsquo;s fees and expenses) caused by taking
or not taking such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Except to enforce the right to receive payment
of principal, premium, if any, or interest when due, no holder of debt securities of a series has any right to institute any proceeding
with respect to the indenture or debt securities, or for the appointment of a receiver or a trustee, or for any other remedy thereunder,
unless:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">such holder has previously given to the trustee written notice of a continuing event of default with
respect to such series of debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the holder or holders of at least 30% in aggregate principal amount of the outstanding debt securities
of that series have made written request, and such holder or holders have offered security or indemnity satisfactory to the trustee against
any fee, cost, damage, claim, loss, liability or expense (including reasonable attorney&rsquo;s fees and expenses), to the trustee to
institute such proceeding as trustee; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the trustee has failed to institute such proceeding, and has not received from the holders of a majority
in aggregate principal amount of the outstanding debt securities of that series a direction inconsistent with such request, within 60&nbsp;days
after such notice, request and offer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">However, such limitations do not apply to a
suit instituted by a holder of a debt security of such series for the enforcement of payment of the principal, premium, if any, or interest
on such debt security on or after the applicable due date specified in such debt security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The indenture provides that if a default with
respect to a series of debt securities occurs and is continuing and is actually known to a responsible officer of the trustee, the trustee
must send to each holder of such debt securities notice of the default within 90&nbsp;days after it is actually known to a responsible
officer of the trustee. Except in the case of a default in the payment of the principal or premium, if any, upon acceleration, redemption
or otherwise with respect to any debt security of a series when such amount becomes due and payable, the trustee may withhold notice if
and so long as a committee of its trust officers in good faith determines that withholding notice is not opposed to the interests of the
holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The indenture requires us to furnish to the
trustee, within 120&nbsp;days after the end of each fiscal year, a statement by certain of our officers as to whether or not we, to their
knowledge, are in default in the performance or observance of any of the terms, provisions and conditions of the indenture and, if so,
specifying all such known defaults. We are also required to deliver to the trustee, within 30&nbsp;days after the occurrence thereof,
written notice of any event which would constitute a default;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that failure to provide such
written notice will not in and of itself result in a default under the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Street name and other indirect holders should
consult their banks and brokers for information on their requirements for giving notice or taking other actions upon a default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Modification and Waiver</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Subject to certain exceptions, modifications
and amendments of the indenture, any supplemental indenture and any series of debt securities may be made by us and the trustee with the
consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of any series affected
by such modification or amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">No such modification or amendment may, without
the consent of each holder affected thereby:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">reduce the&nbsp;percentage of principal amount of the outstanding debt securities, the consent of whose
holders is required for any amendment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">reduce the principal amount of, or interest on, or extend the Stated Maturity (as defined in the indenture)
or interest payment periods of, any debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">change the provisions applicable to the redemption of any debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">make any debt securities payable in money or securities other than those stated in the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">impair the contractual right of any holder of the debt securities to receive payment of principal of
and interest on such holder&rsquo;s debt securities on or after the due dates therefor or to institute suit for the enforcement of any
payment on or with respect to such holder&rsquo;s debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">except as otherwise provided as described under &ldquo;&mdash; Satisfaction and Discharge&rdquo; and
&ldquo;&mdash; Defeasance&rdquo; herein, release any security or guarantee that may have been granted with respect to any debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">in the case of any subordinated securities, or coupons appertaining thereto, make any change in the
provisions of the indenture relating to subordination that adversely affects the rights of any holder under such provisions (including
any contractual subordination of senior unsubordinated debt securities); or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">make any change in the amendment provisions which require each holder&rsquo;s consent or in the waiver
provisions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Without the consent of any holder, we and the
trustee may amend the indenture for one or more of the following purposes:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to cure any ambiguity, omission, defect or inconsistency;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to surrender any right or power conferred upon the Company by the indenture, to add to the covenants
of the Company such further covenants, restrictions, conditions or provisions for the protection of the holders of all or any series of
debt securities as the board of directors of the Company will consider to be for the protection of the holders of such debt securities,
and to make the occurrence, or the occurrence and continuance, of a default in respect of any such additional covenants, restrictions,
conditions or provisions a default or an event of default under the indenture;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that with respect
to any such additional covenant, restriction, condition or provision, such amendment may provide for a period of grace after default,
which may be shorter or longer than that allowed in the case of other defaults, may provide for an immediate enforcement upon such default,
may limit the remedies available to the trustee upon such default or may limit the right of holders of a majority in aggregate principal
amount of the debt securities of any series to waive such default;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to provide for the assumption by a successor company of the obligations of the Company under the indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to add guarantees with respect to the debt securities or to secure the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to make any change that does not adversely affect in any material respect the rights of any holder of
the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to add to, change, or eliminate any of the provisions of the indenture with respect to one or more series
of debt securities, so long as any such addition, change or elimination not otherwise permitted under the indenture will (a)&nbsp;neither
apply to any debt securities of any series created prior to the</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.75in">execution of such supplemental indenture and entitled to
the benefit of such provision nor modify the rights of the holders of any such debt securities with respect to the benefit of such provision
or (b)&nbsp;become effective only when there is no such debt securities outstanding;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to evidence and provide for the acceptance of appointment by a successor or separate trustee with respect
to the debt securities of one or more series and to add to or change any of the provisions of the indenture as shall be necessary to provide
for or facilitate the administration of the indenture by more than one trustee;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to add or to change any of the provisions of the indenture to provide that debt securities in bearer
form may be registrable as to principal, to change or eliminate any restrictions on the payment of principal or premium with respect to
debt securities in registered form or of principal, premium or interest with respect to debt securities in bearer form, or to permit debt
securities in registered form to be exchanged for debt securities in bearer form, so as to not adversely affect the interests of the holders
of debt securities or any coupons of any series in any material respect or permit or facilitate the issuance of debt securities of any
series in uncertificated form;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">in the case of subordinated debt securities, to make any change in the provisions of the indenture or
any supplemental indenture relating to subordination that would limit or terminate the benefits available to any holder of senior Indebtedness
under such provisions (but only if each such holder of senior Indebtedness consents to such change);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to comply with any requirement of the SEC in connection with the qualification of the indenture or any
supplemental indenture under the Trust Indenture Act;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to conform any provision in the indenture or the debt securities to the description of any debt securities
in an offering document;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to approve a particular form of any proposed amendment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to provide for the issuance of additional debt securities of any series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to establish the form or terms of debt securities and coupons of any series pursuant to the indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to comply with the rules of any applicable depositary;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to make any amendment to the provisions of the indenture relating to the transfer and legending of debt
securities;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that (a)&nbsp;compliance with the indenture as so amended would not result in debt
securities being transferred in violation of the Securities Act or any other applicable securities law and (b)&nbsp;such amendment does
not materially and adversely affect the rights of holders of debt securities to transfer debt securities; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to convey, transfer, assign, mortgage or pledge any property to or with the trustee, or to make such
other provisions in regard to matters or questions arising under the indenture as shall not adversely affect, in any material respect,
the interests of any holders of debt securities of any series.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Mergers and Sales of Assets</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The indenture provides that we will not
consolidate with or merge with or into, or convey, transfer or lease in one transaction or a series of related transactions,
directly or indirectly, all or substantially all of our properties and assets to, another person, unless (i)&nbsp;the resulting,
surviving or transferee person, if not Red Robin Gourmet Burgers, Inc., is a person organized and existing under the laws of the
United States of America, any state thereof or the District of Columbia; (ii)&nbsp;immediately after giving effect to such
transaction, no default or event of default has occurred and is continuing under the indenture; (iii)&nbsp;the resulting, surviving
or transferee person, if not Red Robin Gourmet Burgers, Inc., expressly assumes by supplemental indenture in a form satisfactory to
the trustee all of our obligations under the debt securities and the indenture; and (iv)&nbsp;we or the successor person has
delivered to the trustee the certificates and opinions of counsel required under the indenture. Upon any such consolidation, merger
or transfer, the resulting, surviving or transferee person shall succeed to, and may exercise every right and power of, Red Robin
Gourmet Burgers, Inc. under the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Satisfaction and Discharge of the Indenture; Defeasance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Unless otherwise provided for in the prospectus
supplement, the indenture will generally cease to be of any further effect with respect to a series of debt securities if (a)&nbsp;we
have delivered to the trustee for cancellation all debt securities of such series (with certain limited exceptions) or (b)&nbsp;all debt
securities and coupons of such series not theretofore delivered to the trustee for cancellation will have become due and payable, or are
by their terms to become due and payable within one year or are to be called for redemption within one year, and we will have deposited
with the trustee as trust funds the entire amount sufficient to pay at maturity or upon redemption all such debt securities and coupons
(and if, in either case, we will also pay or cause to be paid all other sums payable under the indenture by us).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In addition, we will have a &ldquo;legal defeasance
option&rdquo; (pursuant to which we may terminate, with respect to the debt securities of a particular series, all of our obligations
under such debt securities and the indenture with respect to such debt securities) and a &ldquo;covenant defeasance option&rdquo; (pursuant
to which we may terminate, with respect to the debt securities of a particular series, our obligations with respect to such debt securities
under certain specified covenants contained in the indenture). If we exercise our legal defeasance option with respect to a series of
debt securities, payment of such debt securities may not be accelerated because of an event of default. If we exercise our covenant defeasance
option with respect to a series of debt securities, payment of such debt securities may not be accelerated because of an event of default
related to the specified covenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The applicable prospectus supplement will describe
the procedures we must follow in order to exercise our defeasance options.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Regarding the Trustee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The indenture provides that, except during the
continuance of an event of default, the trustee will perform only such duties as are specifically set forth in the indenture. During the
existence of an event of default, the trustee may exercise such rights and powers vested in it under the indenture and use the same degree
of care and skill in its exercise as a prudent person would exercise under the circumstances in the conduct of such person&rsquo;s own
affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The indenture and provisions of the Trust Indenture
Act that are incorporated by reference therein contain limitations on the rights of the trustee, should it become one of our creditors,
to obtain payment of claims in certain cases or to realize on certain property received by it in respect of any such claim as security
or otherwise. The trustee will be permitted to engage in other transactions with us or any of our affiliates;&nbsp;<I>provided</I>,&nbsp;<I>however</I>,
that if it acquires any conflicting interest (as defined in the indenture or in the Trust Indenture Act), it must eliminate such conflict,
apply to the SEC for permission to continue, or resign.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Governing Law</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The indenture and the debt securities will be
governed by, and construed in accordance with, the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_010"></A>DESCRIPTION OF DEPOSITARY SHARES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">General</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may, at our option, elect to offer fractional
shares rather than full shares of the preferred stock of a series. In the event that we determine to do so, we will issue receipts for
depositary shares, each of which will represent a fraction (to be set forth in the prospectus supplement relating to a particular series
of preferred stock) of a share of a particular series of preferred stock as more fully described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The shares of any series of preferred stock
represented by depositary shares will be deposited under one or more deposit agreements among us, a depositary to be named in the applicable
prospectus supplement, and the holders from time to time of depositary receipts issued thereunder. Subject to the terms of the applicable
deposit agreement, each holder of a depositary share will be entitled, in proportion to the applicable fraction of a share of preferred
stock represented by the depositary share, to all the rights and preferences of the preferred stock represented thereby (including, as
applicable, dividend, voting, redemption, subscription and liquidation rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The depositary shares will be evidenced by depositary
receipts issued pursuant to the deposit agreement. Depositary receipts will be distributed to those persons purchasing the fractional
shares of the related series of preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The following description sets forth certain
general terms and provisions of the depositary shares to which any prospectus supplement may relate. The particular terms of the depositary
shares to which any prospectus supplement may relate and the extent, if any, to which such general provisions may apply to the depositary
shares so offered will be described in the applicable prospectus supplement. To the extent that any particular terms of the depositary
shares or the deposit agreement described in a prospectus supplement differ from any of the terms described below, then the terms described
below will be deemed to have been superseded by that prospectus supplement relating to such deposited shares. The forms of deposit agreement
and depositary receipt will be filed as exhibits to the documents incorporated or deemed to be incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The following summary of certain provisions
of the depositary shares and deposit agreement does not purport to be complete and is subject to, and is qualified in its entirety by
express reference to, all the provisions of the deposit agreement and the applicable prospectus supplement, including the definitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Immediately following our issuance of shares
of a series of preferred stock that will be offered as fractional shares, we will deposit the shares with the depositary, which will then
issue and deliver the depositary receipts to the purchasers thereof. Depositary receipts will only be issued evidencing whole depositary
shares. A depositary receipt may evidence any number of whole depositary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Pending the preparation of definitive depositary
receipts, the depositary may, upon our written order, issue temporary depositary receipts substantially identical to (and entitling the
holders thereof to all the rights pertaining to) the definitive depositary receipts but not in definitive form. Definitive depositary
receipts will be prepared thereafter without unreasonable delay, and such temporary depositary receipts will be exchangeable for definitive
depositary receipts at our expense.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Dividends and Other Distributions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The depositary will distribute all cash dividends
or other cash distributions received in respect of the related series of preferred stock to the record holders of depositary shares relating
to the series of preferred stock in proportion to the number of the depositary shares owned by the holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In the event of a distribution other than
in cash, the depositary will distribute property received by it to the record holders of depositary shares entitled thereto in
proportion to the number of depositary shares owned by the holders, unless the depositary determines that the distribution cannot be
made proportionately among the holders or that it is not feasible to make the distributions, in which case the depositary may, with
our approval, adopt any method as it deems equitable and practicable for the purpose of effecting the distribution, including the
sale (at public or private sale) of the securities or property thus received, or any part thereof, at the place or places and upon
those terms as it may deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The amount distributed in any of the foregoing
cases will be reduced by any amounts required to be withheld by us or the depositary on account of taxes or other governmental charges.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Redemption of Depositary Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">If any series of the preferred stock underlying
the depositary shares is subject to redemption, the depositary shares will be redeemed from the proceeds received by the depositary resulting
from any redemption, in whole or in part, of the series of the preferred stock held by the depositary. The redemption price per depositary
share will be equal to the applicable fraction of the redemption price per share payable with respect to the series of the preferred stock.
If we redeem shares of a series of preferred stock held by the depositary, the depositary will redeem as of the same redemption date the
number of depositary shares representing the shares of preferred stock so redeemed. If less than all the depositary shares are to be redeemed,
the depositary shares to be redeemed will be selected by lot or substantially equivalent method determined by the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">After the date fixed for redemption, the depositary
shares so called for redemption will no longer be deemed to be outstanding and all rights of the holders of the depositary shares will
cease, except the right to receive the monies payable upon redemption and any money or other property to which the holders of the depositary
shares were entitled upon such redemption, upon surrender to the depositary of the depositary receipts evidencing the depositary shares.
Any funds deposited by us with the depositary for any depositary shares that the holders thereof fail to redeem will be returned to us
after a period of two&nbsp;years from the date the funds are so deposited.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Voting the Underlying Preferred Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Upon receipt of notice of any meeting at which
the holders of any series of the preferred stock are entitled to vote, the depositary will mail the information contained in the notice
of meeting to the record holders of the depositary shares relating to the series of preferred stock. Each record holder of the depositary
shares on the record date (which will be the same date as the record date for the related series of preferred stock) will be entitled
to instruct the depositary as to the exercise of the voting rights pertaining to the number of shares of the series of preferred stock
represented by that holder&rsquo;s depositary shares. The depositary will endeavor, insofar as practicable, to vote or cause to be voted
the number of shares of preferred stock represented by the depositary shares in accordance with the instructions, provided the depositary
receives the instructions sufficiently in advance of the meeting to enable it to so vote or cause to be voted the shares of preferred
stock, and we will agree to take all reasonable action that may be deemed necessary by the depositary in order to enable the depositary
to do so. The depositary will abstain from voting shares of the preferred stock to the extent it does not receive specific instructions
from the holders of depositary shares representing the preferred stock.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Withdrawal of Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Upon surrender of the depositary receipts at
the corporate trust office of the depositary and upon payment of the taxes, charges and fees provided for in the deposit agreement and
subject to the terms thereof, the holder of the depositary shares evidenced thereby will be entitled to delivery at such office, to or
upon his or her order, of the number of whole shares of the related series of preferred stock and any money or other property, if any,
represented by the depositary shares. Holders of depositary shares will be entitled to receive whole shares of the related series of preferred
stock, but holders of the whole shares of preferred stock will not thereafter be entitled to deposit the shares of preferred stock with
the depositary or to receive depositary shares therefor. If the depositary receipts delivered by the holder evidence a number of depositary
shares in excess of the number of depositary shares representing the number of whole shares of the related series of preferred stock to
be withdrawn, the depositary will deliver to the holder or upon his or her order at the same time a new depositary receipt evidencing
the excess number of depositary shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Amendment and Termination of a Deposit Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The form of depositary receipt evidencing the
depositary shares of any series and any provision of the applicable deposit agreement may at any time and from time to time be amended
by agreement between us</P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">and the depositary. However, any amendment that materially adversely
alters the rights of the holders of depositary shares of any series will not be effective unless the amendment has been approved by the
holders of at least a majority of the depositary shares of the series then outstanding. Every holder of a depositary receipt at the time
the amendment becomes effective will be deemed, by continuing to hold the depositary receipt, to be bound by the deposit agreement as
so amended. Notwithstanding the foregoing, in no event may any amendment impair the right of any holder of any depositary shares, upon
surrender of the depositary receipts evidencing the depositary shares and subject to any conditions specified in the deposit agreement,
to receive shares of the related series of preferred stock and any money or other property represented thereby, except in order to comply
with mandatory provisions of applicable law. The deposit agreement may be terminated by us at any time upon not less than 60&nbsp;days
prior written notice to the depositary, in which case, on a date that is not later than 30&nbsp;days after the date of the notice, the
depositary shall deliver or make available for delivery to holders of depositary shares, upon surrender of the depositary receipts evidencing
the depositary shares, the number of whole or fractional shares of the related series of preferred stock as are represented by the depositary
shares. The deposit agreement shall automatically terminate after all outstanding depositary shares have been redeemed or there has been
a final distribution in respect of the related series of preferred stock in connection with any liquidation, dissolution or winding up
of us and the distribution has been distributed to the holders of depositary shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Charges of Depositary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We will pay all transfer and other taxes and
the governmental charges arising solely from the existence of the depositary arrangements. We will pay the charges of the depositary,
including charges in connection with the initial deposit of the related series of preferred stock and the initial issuance of the depositary
shares and all withdrawals of shares of the related series of preferred stock, except that holders of depositary shares will pay transfer
and other taxes and governmental charges and any other charges as are expressly provided in the deposit agreement to be for their accounts.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Resignation and Removal of Depositary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The depositary may resign at any time by delivering
to us written notice of its election to do so, and we may at any time remove the depositary. Any resignation or removal will take effect
upon the appointment of a successor depositary, which successor depositary must be appointed within 60&nbsp;days after delivery of the
notice of resignation or removal and must be a bank or trust company having its principal office in the United States and having a combined
capital and surplus of at least $50,000,000.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Miscellaneous</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The depositary will forward to the holders of
depositary shares all reports and communications from us that are delivered to the depositary and which we are required to furnish to
the holders of the related preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The depositary&rsquo;s corporate trust office
will be identified in the applicable prospectus supplement. Unless otherwise set forth in the applicable prospectus supplement, the depositary
will act as transfer agent and registrar for depositary receipts and if shares of a series of preferred stock are redeemable, the depositary
will also act as redemption agent for the corresponding depositary receipts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_011"></A>DESCRIPTION OF THE WARRANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The following description of the terms of the
warrants sets forth certain general terms and provisions of the warrants to which any prospectus supplement may relate. We may issue warrants
for the purchase of common stock, preferred stock, debt securities or depositary shares. Warrants may be issued independently or together
with common stock, preferred stock, debt securities or depositary shares offered by any prospectus supplement and may be attached to or
separate from any such offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into
between us and a bank or trust company, as warrant agent. The warrant agent will act solely as our agent in connection with the warrants
and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. The following
summary of certain provisions of the warrants does not purport to be complete and is subject to, and qualified in its entirety by reference
to, the provisions of the warrant agreement that will be filed with the SEC in connection with the offering of such warrants.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Debt Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The prospectus supplement relating to a particular
issue of debt warrants will describe the terms of such debt warrants, including the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the title of such debt warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the offering price for such debt warrants, if any;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the aggregate number of such debt warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the designation and terms of the debt securities purchasable upon exercise of such debt warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, the designation and terms of the debt securities with which such debt warrants are issued
and the number of such debt warrants issued with each such debt security;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, the date from and after which such debt warrants and any debt securities issued therewith
will be separately transferable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the principal amount of debt securities purchasable upon exercise of a debt warrant and the price at
which such principal amount of debt securities may be purchased upon exercise (which price may be payable in cash, securities or other
property);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the date on which the right to exercise such debt warrants shall commence and the date on which such
right shall expire;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, the minimum or maximum amount of such debt warrants that may be exercised at any one
time;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">whether the debt warrants represented by the debt warrant certificates or debt securities that may be
issued upon exercise of the debt warrants will be issued in registered or bearer form;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">information with respect to book-entry procedures, if any;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the currency or currency&nbsp;units in which the offering price, if any, and the exercise price are
payable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, a discussion of material United States federal income tax considerations;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the antidilution or adjustment provisions of such debt warrants, if any;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the redemption or call provisions, if any, applicable to such debt warrants; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any additional terms of such debt warrants, including terms, procedures, and limitations relating to
the exchange and exercise of such debt warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0pt">Stock Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The prospectus supplement relating to any particular
issue of common stock warrants, preferred stock warrants or depositary share warrants will describe the terms of such warrants, including
the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the title of such warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the offering price for such warrants, if any;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the aggregate number of such warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the designation and terms of the offered securities purchasable upon exercise of such warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, the designation and terms of the offered securities with which such warrants are issued
and the number of such warrants issued with each such offered security;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, the date from and after which such warrants and any offered securities issued therewith
will be separately transferable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the number of shares of common stock, preferred stock or depositary shares purchasable upon exercise
of a warrant and the price at which such shares may be purchased upon exercise;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the date on which the right to exercise such warrants shall commence and the date on which such right
shall expire;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, the minimum or maximum amount of such warrants that may be exercised at any one time;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the currency or currency&nbsp;units in which the offering price, if any, and the exercise price are
payable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, a discussion of material United States federal income tax considerations;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the antidilution provisions of such warrants, if any;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the redemption or call provisions, if any, applicable to such warrants; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any additional terms of such warrants, including terms, procedures and limitations relating to the exchange
and exercise of such warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_012"></A>DESCRIPTION OF THE RIGHTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may issue rights to purchase our common stock.
The rights may or may not be transferable by the persons purchasing or receiving the rights. In connection with any rights offering, we
may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters
or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. Each series of rights will
be issued under a separate rights agent agreement to be entered into between us and one or more banks, trust companies or other financial
institutions, as rights agent, that we will name in the applicable prospectus supplement. The rights agent will act solely as our agent
in connection with the rights and will not assume any obligation or relationship of agency or trust for or with any holders of rights
certificates or beneficial owners of rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The prospectus supplement relating to any rights
that we offer will include specific terms relating to the offering, including, among other matters:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the date of determining the security holders entitled to the rights distribution;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the aggregate number of rights issued and the aggregate number of shares of common stock purchasable
upon exercise of the rights;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the exercise price;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the conditions to completion of the rights offering;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the date on which the right to exercise the rights will commence and the date on which the rights will
expire; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if applicable, a discussion of material United States federal income tax considerations.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Each right would entitle the holder of the rights
to purchase for cash the principal amount of shares of common stock at the exercise price set forth in the applicable prospectus supplement.
Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus
supplement. After the close of business on the expiration date, all unexercised rights will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">If less than all of the rights issued in any
rights offering are exercised, we may offer any unsubscribed securities directly to persons other than our security holders, to or through
agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in
the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_013"></A>DESCRIPTION OF THE PURCHASE CONTRACTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may issue, from time to time, purchase contracts,
including contracts obligating holders to purchase from us and us to sell to the holders, a specified principal amount of debt securities,
shares of common stock or preferred stock, depositary shares, government securities, or other securities that we may sell under this prospectus
at a future date or dates. The consideration payable upon settlement of the purchase contracts may be fixed at the time the purchase contracts
are issued or may be determined by a specific reference to a formula set forth in the purchase contracts. The purchase contracts may be
issued separately or as part of&nbsp;units consisting of a purchase contract and other securities or obligations issued by us or third
parties, including United States treasury securities, securing the holders&rsquo; obligations to purchase the relevant securities under
the purchase contracts. The purchase contracts may require us to make periodic payments to the holders of the purchase contracts or&nbsp;units
or vice versa, and the payments may be unsecured or prefunded on some basis. The purchase contracts may require holders to secure their
obligations under the purchase contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The prospectus supplement related to any particular
purchase contracts will describe, among other things, the material terms of the purchase contracts and of the securities being sold pursuant
to such purchase contracts, a discussion, if appropriate, of any material United States federal income tax considerations applicable to
the purchase contracts and any material provisions governing the purchase contracts that differ from those described above. The description
in the prospectus supplement will not necessarily be complete and will be qualified in its entirety by reference to the purchase contracts,
and, if applicable, collateral arrangements and depositary arrangements, relating to the purchase contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_014"></A>DESCRIPTION OF THE UNITS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may, from time to time, issue&nbsp;units
comprised of one or more of certain other securities that may be offered under this prospectus, in any combination. Each unit may also
include debt obligations of third parties, such as United States Treasury securities. Each unit will be issued so that the holder of the
unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder
of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not
be held or transferred separately at any time, or at any time before a specified date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Any prospectus supplement related to any particular&nbsp;units
will describe, among other things:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the material terms of the&nbsp;units and of the securities comprising the&nbsp;units, including whether
and under what circumstances those securities may be held or transferred separately;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any material provisions relating to the issuance, payment, settlement, transfer or exchange of the&nbsp;units
or of the securities comprising the&nbsp;units;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">if appropriate, any material United States federal income tax considerations applicable to the&nbsp;units;
and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any material provisions of the governing unit agreement that differ from those described above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_015"></A>PLAN OF DISTRIBUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may offer and sell the securities in any
one or more of the following ways:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">to or through underwriters, brokers or dealers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">directly to one or more other purchasers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">through a block trade in which the broker or dealer engaged to handle the block trade will attempt to
sell the securities as agent, but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">through agents on a best-efforts basis; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">otherwise through a combination of any of the above methods of sale.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In addition, we may enter into option, share
lending or other types of transactions that require us to deliver shares of common stock to an underwriter, broker or dealer, who will
then resell or transfer the shares of common stock under this prospectus. We may also enter into hedging transactions with respect to
our securities. For example, we may:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">enter into transactions involving short sales of the shares of common stock by underwriters, brokers
or dealers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">sell shares of common stock short and deliver the shares to close out short positions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">enter into option or other types of transactions that require us to deliver shares of common stock to
an underwriter, broker or dealer, who will then resell or transfer the shares of common stock under this prospectus; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">loan or pledge the shares of common stock to an underwriter, broker or dealer, who may sell the loaned
shares or, in the event of default, sell the pledged shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may enter into derivative transactions with
third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable
prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus
and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us
or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received
from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions
will be an underwriter and, if not identified in this prospectus, will be identified in the applicable prospectus supplement (or a post-effective
amendment). In addition, we may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell
the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to
investors in our securities or in connection with a concurrent offering of other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Each time we sell securities pursuant to this
prospectus, we will provide a prospectus supplement that will name any underwriter, dealer or agent involved in the offer and sale of
the securities. The prospectus supplement will also set forth the terms of the offering, including:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the purchase price of the securities and the proceeds we will receive from the sale of the securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any underwriting discounts and other items constituting underwriters&rsquo; compensation;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any public offering or purchase price and any discounts or commissions allowed or re-allowed or paid
to dealers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any commissions allowed or paid to agents;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any other offering expenses;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any securities exchanges on which the securities may be listed;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the method of distribution of the securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">the terms of any agreement, arrangement or understanding entered into with the underwriters, brokers
or dealers; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">any other required information or information we think is important.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">If underwriters or dealers are used in the sale,
the securities will be acquired by the underwriters or dealers for their own account. The securities may be sold from time to time by
us in one or more transactions:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">at a fixed price or prices that may be changed;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">at market prices prevailing at the time of sale;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">at prices related to such prevailing market prices;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">at varying prices determined at the time of sale; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">at negotiated prices.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Such sales may be effected:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">in transactions on any national securities exchange or quotation service on which the securities may
be listed or quoted at the time of sale;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">in transactions in the over-the-counter market;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">in block transactions in which the broker or dealer so engaged will attempt to sell the securities as
agent but may position and resell a portion of the block as principal to facilitate the transaction, or in crosses, in which the same
broker acts as an agent on both sides of the trade;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">through the writing of options; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">through other types of transactions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The securities may be offered to the public
either through underwriting syndicates represented by one or more managing underwriters or directly by one or more of such firms. Unless
otherwise set forth in the prospectus supplement, the obligations of underwriters or dealers to purchase the securities offered will be
subject to certain conditions precedent and the underwriters or dealers will be obligated to purchase all the offered securities if any
are purchased. Any public offering price and any discount or concession allowed or reallowed or paid by underwriters or dealers to other
dealers may be changed from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We may offer our equity securities into an existing
trading market on the terms described in the applicable prospectus supplement. Underwriters, dealers and agents who may participate in
any at-the-market offerings will be described in the prospectus supplement relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Any shares of common stock covered by this prospectus
that qualify for sale pursuant to Rule&nbsp;144 under the Securities Act may be sold under Rule&nbsp;144 rather than pursuant to this
prospectus. Any shares of common stock offered under this prospectus will be listed on the Nasdaq Global Select Market (or other such
exchange or automated quotation system on which the common stock is listed), subject to official notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The securities may be sold directly by us or
through agents designated by us from time to time. Any agent involved in the offer or sale of the securities in respect of which this
prospectus is delivered will be named, and any commissions payable by us to such agent will be set forth in, the prospectus supplement.
Unless otherwise indicated in the prospectus supplement, any such agent will be acting on a best efforts basis for the period of its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Offers to purchase the securities offered by
this prospectus may be solicited, and sales of the securities may be made by us directly to institutional investors or others, who may
be deemed to be underwriters within the meaning of the Securities Act with respect to any resale of the securities. The terms of any offer
made in this manner will be included in the prospectus supplement relating to the offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">If indicated in the applicable prospectus supplement,
underwriters, dealers or agents will be authorized to solicit offers by certain institutional investors to purchase securities from us
pursuant to contracts providing for payment and delivery at a future date. Institutional investors with which these contracts may be made
include, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">commercial and savings banks;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">insurance companies;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">pension funds;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">investment companies; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD><FONT STYLE="font-size: 10pt">educational and charitable institutions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">In all cases, these purchasers must be approved
by us. Unless otherwise set forth in the applicable prospectus supplement, the obligations of any purchaser under any of these contracts
will not be subject to any conditions except that (a)&nbsp;the purchase of the securities must not at the time of delivery be prohibited
under the laws of any jurisdiction to which that purchaser is subject, and (b)&nbsp;if the securities are also being sold to underwriters,
we must have sold to these underwriters the securities not subject to delayed delivery. Underwriters and other agents will not have any
responsibility in respect of the validity or performance of these contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Some of the underwriters, dealers or agents
used by us in any offering of securities under this prospectus may be customers of, engage in transactions with, and perform services
for us or affiliates of ours in the ordinary course of business. Underwriters, dealers, agents and other persons may be entitled under
agreements which may be entered into with us to indemnification against and contribution toward certain civil liabilities, including liabilities
under the Securities Act, and to be reimbursed by us for certain expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Subject to any restrictions relating to debt
securities in bearer form, any securities initially sold outside the United States may be resold in the United States through underwriters,
dealers or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Any underwriters to which offered securities
are sold by us for public offering and sale may make a market in such securities, but those underwriters will not be obligated to do so
and may discontinue any market making at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The anticipated date of delivery of the securities
offered by this prospectus will be described in the applicable prospectus supplement relating to the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">To comply with the securities laws of some states,
if applicable, the securities may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition,
in some states the securities may not be sold unless they have been registered or qualified for sale or an exemption from registration
or qualification requirements is available and is complied with.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_016"></A>LEGAL MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Unless otherwise indicated in the applicable
prospectus supplement, certain legal matters will be passed upon for us by Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP, New York,
New York. If legal matters in connection with offerings made pursuant to this prospectus are passed upon by counsel for underwriters,
dealers or agents, if any, such counsel will be named in the prospectus supplement relating to such offering.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="b_017"></A>EXPERTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The consolidated financial statements of Red
Robin Gourmet Burgers, Inc. incorporated by reference in this prospectus, and the effectiveness of Red Robin Gourmet Burgers, Inc.&rsquo;s
internal control over financial reporting have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting
firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm, given
their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><A HREF="#toc" TITLE="Table of Contents">Table of Contents</A></TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Sans-Serif; margin: 0; text-align: center; color: Red"><B><IMG SRC="rrgb.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Red Robin Gourmet
Burgers, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>$75,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Debt Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Depositary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Purchase Contracts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Units</B></FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 47; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !> ,P# 2(  A$! Q$!_\0
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>!F9%*K\N#CW/>M&M\(JD:=JE[^;O^K,J[BY^Z?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>rrgb.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rrgb.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #__@ 23$5!1%1/3TQ3('8R,BXP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
M 0(#! 4&!P@)"@L0  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B
M<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'
M2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JB
MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ
M\?+S]/7V]_CY^A$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B
M,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'
M2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:
MHJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ
M\O/T]?;W^/GZ_\  $0@ ;P#, P$1  (1 0,1 ?_:  P# 0 "$0,1 #\ ^RZ
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M^5_@?3T<V<H_5\Q@J]+NTN=>:?5KOH_,?X?^)<]C=#1?%\)TZ]Z).1_H\W.
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MY8_OHKJ77_>4'*_B!71=/1-7['C2HU(152<)QA+X9.+47Z-JS^1:JC$* "@
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MQX.'--S>T5^+/J>*<5['#0PD7[U:5W_@AJ_ODTO/4^FKB9;:)YG.U(U9V)Z
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M5[!L-+"$&/O1O(RQ.#Z-&6;!]0",@@U]!4J\U!U(=5;T;T?W'XI@\M=+-J>
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MP,\XS44Z4*7P*WGU.C&9AB<P:>*J.26T=%%>D597\W=^9T-;'EA0 4 % !0
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5 4 % !0 4 % !0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
